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Keratoconus is a corneal disease characterized by the affected tissue adopting a conical shape, 
leading to loss of vision and compromised structural integrity. The disease is manageable in 
its early stage with lenses or glasses and can be treated in its later stages with surgery or 
crosslinking. The underlying cause of the disease is still poorly understood, a model would 
aid the exploration of this disease. In this study, primary stromal cells harvested from healthy 
and keratoconic corneas using a variety of extraction methods were cultured in compressed 
collagen gels and serum-free medium containing retinoic acid to simulate the cornea’s natural 
environment. The survival of stromal cells and their gene expression was assayed, paying 
special attention to genes related to differentiation and ECM maintenance. Among healthy 
cells, differences were identified between limbal and central population while central 
keratoconic cells more closely resembled healthy limbal cells. Use of retinoic acid as a 
medium supplement allowed for the culture of cells in serum-free conditions and caused gene 
expression that resembled in vivo behaviour. The final addition of ECM in the form of curved, 
compressed collagen gels to this culture system caused the stromal cells to radically change 
their behaviour and reaction to retinoic acid. Overall, this study identified a stromal tissue 
model as well as the multiple considerations in the construction of such a model. The use of 
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Chapter 1: Introduction 
1. Thesis abstract 
Keratoconus is a corneal disease characterized by the affected tissue adopting a conical shape, 
leading to loss of vision and compromised structural integrity. The disease is manageable in 
its early stage with lenses or glasses and can be treated in its later stages with surgery or 
crosslinking. The underlying cause of the disease is still poorly understood, a model would 
aid the exploration of this disease. In this study, primary stromal cells harvested from healthy 
and keratoconic corneas using a variety of extraction methods were cultured in compressed 
collagen gels and serum-free medium containing retinoic acid to simulate the cornea’s natural 
environment. The survival of stromal cells and their gene expression was assayed, paying 
special attention to genes related to differentiation and ECM maintenance. Among healthy 
cells, differences were identified between limbal and central population while central 
keratoconic cells more closely resembled healthy limbal cells. Use of retinoic acid as a 
medium supplement allowed for the culture of cells in serum-free conditions and caused gene 
expression that resembled in vivo behaviour. The final addition of ECM in the form of curved, 
compressed collagen gels to this culture system caused the stromal cells to radically change 
their behaviour and reaction to retinoic acid. Overall, this study identified a stromal tissue 
model as well as the multiple considerations in the construction of such a model. The use of 
this model in keratoconus research may lead to breakthroughs in attempts to better understand 
the disease. 
 
2. Thesis structure 
Chapter 2. Literature review 
In this chapter, we reviewed the anatomy of the healthy human cornea as well as catalogued 
diagnostic signs and molecular pathways of keratoconus. Current approaches and existing 
challenges in the construction of 3D culture systems and disease models were also mentioned. 
 
Chapter 3. General methodology 
In this chapter we described the culture conditions and extraction methods used to isolate 
primary stromal cells from donor tissue. The fabrication of the 3D culture system and the 
assays used to monitor cell survival or gene expression were also mentioned. The imitations 
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and initial troubleshooting involved in some of these methods was also discussed. Lastly, 
statistical analysis and data processing methods were explained. 
Chapter 4. Isolation of stromal cells from different parts of the cornea 
In this chapter we investigated the effects that the isolation method and location had on the 
final population extracted cells. Through 3 distinct methods and 2 distinct pieces of tissue, it 
was possible to isolate a total of 6 different populations of stromal cells. After analysis of 
survival and gene expression it became clear that isolation method and location had 
significant effects on the cells extracted. Lastly, keratoconic cells were factored into this 
comparison and we observed great similarity between the central, explant-migrated 
keratoconic cells and the limbal, enzyme-digested healthy cells. 
 
Chapter 5. Culturing Stromal Cells in Serum-Free Conditions 
In this chapter the use of retinoic acid was explored as a medium supplement to maintain cell 
survival in serum-free conditions. Assays determined that retinoic acid had a significant effect 
on survival and gene expression of both healthy and keratoconic cells. The expression profiles 
of healthy cells seemed to mimic in vivo behaviour, suggesting that retinoic acid is a useful 
addition to the model system. 
 
Chapter 6. Engineering a 3D culture system 
In this chapter the use of compressed collagen gels was investigated as a means to produce 
stroma-like tissue to house the primary cells extracted previously. The survival and gene 
expression of the cells were assayed, showing distinct shifts in behaviour from culture on flat 
plastic in both healthy and keratoconic cells. Addition of retinoic acid and curving the 
compressed collagen gels were also explored as means to better model stromal conditions. 
Retinoic acid did seem to have a beneficial effect while the effect of curvature was more 
complex to interpret.  
 
Chapter 7. Validation of the artificial stroma model 
In this chapter the validity of the culture system developed as a model was assayed using 
qPCR and RNA-Seq. The gene expression of healthy cells cultured in the model was 
compared to freshly isolated cells while keratoconic cells cultured in the model were 
compared to patient samples. Key differences between the model cultures and their respective 
baselines were highlighted.  
 3 
Chapter 8. Conclusions and future directions 
This chapter summarizes the main findings of this thesis and the potential implications for 
corneal research. Potential future developments and interesting new challenges are also 
detailed. 
 
3. List of abbreviations 
enzdL - enzyme digested limbal stromal cell 
enzdC - enzyme digested central stromal cell 
exmL – explant migrated limbal stromal cell 
exmC – explant migrated central stromal cell 
exenzdL – “explant” enzyme digested limbal stromal cell 
exenzdC - “explant” enzyme digested central stromal cell 
CCG – compressed collagen gel 
cCCG – curved compressed collagen gel 
RA – retinoic acid 
ECM – extra cellular matrix 





Chapter 2: Literature review 
1. Anatomy of the human cornea 
The front of the eye is protected by a clear spherical cap of tissue called the cornea (Fig. 1). 
The clarity and shape of the cornea are both essential to allow transmission of light into the 
eye and to the retina. The cornea also serves as a physical barrier and protects the inner 
contents of the eye. The human cornea is made up of five distinct layers (Fig. 2). The anterior-
most layer is the cell-rich epithelium. The epithelium’s basal cells reside on an underlying 
fibrous mesh of collagen called the Bowman layer. Posterior to the Bowman layer is the 
collagen-rich stroma, contributing the majority of the cornea’s volume. Posterior to the stroma 
is the acellular Descemet's membrane. The final and posterior-most layer of the cornea is the 
single cell layer of endothelium that separates the cornea from the aqueous humour in the eye 
(Schwarz and Keyserlingk, 1966, Maurice, 1957).  
 
The centre of the cornea is avascular and is sustained by nutrients provided from the aqueous 
humour and tear film. The periphery of the cornea, referred to as the limbus, has some blood 
supply due to the proximity to the vascularized conjunctiva that covers the rest of the eye’s 
surface (Sridhar, 2018). The corneal structure does vary between species, particularly in terms 
of Bowman layer and Descemet’s membranes, to accommodate different needs and 
adaptations, although in all cases the cornea fulfils the basic roles of protection and refraction 
(Hayashi et al., 2002a).   
 




1.1 Tear fluid 
A thin film of tear fluid covers every part of the eye that is exposed to the outside world. This 
fluid is full of lipids, proteins and salts that fulfil many functions: lubrication, microbial 
defence, inflammatory regulation and wound healing (Kijlstra and Kuizenga, 1994, Georgiev 
et al., 2017). The fluid that covers the cornea specifically is termed the precorneal tear fluid 
(Mishima, 1965). This tear film can be considered the most dynamic structure of the cornea, 
with the most rapid production and turnover (Rolando and Zierhut, 2001). During wounding 
events, factors that are normally kept from penetrating into the corneal tissue by the 
epithelium can enter the stroma and disturb the cells within. 
 
Figure 2: Schematic cross-section of the tissue layers in the central cornea and the 
approximate shape of cells within each layer. The Bowman layer and Descemet’s 
membrane are both devoid of cells 
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1.2. Epithelium 
The corneal epithelium covers the anterior portion of the corneal stroma and is composed of 
stratified, non-cornified, squamous cells. The epithelium’s basal layer of cuboidal cells 
adheres to the top of the Bowman layer (Tong et al., 2006) via a basement membrane. Like in 
all parts of the human anatomy, the main purpose of the epithelium is to form a protective 
barrier to the outside. Along with its protective role, the corneal epithelium has also been 
found to produce cytokines that influence keratocyte behaviour. Epithelial wounding events 
may cause loss of cells that can then allow infiltration of previously isolated cytokines into 
the posterior layers or the loss of pre-existing signals (Lackner et al., 2014). An example is 
TGFβ in its three isoforms, which can increase ECM production and proliferation of stromal 
keratocytes; or interleukins 1 and 6 that may trigger ECM remodelling and antagonize TGFβ 
signalling.  The maintenance of the corneal ECM structure and transparency is an active and 
dynamic process that requires continuous communication between the stromal keratocyte and 
the neighbouring cells located at separate layers of the cornea. Distinct populations of cells in 
the epithelium, stroma and endothelium use cytokine-mediated interactions to communicate 
across the Bowman layer and Descemet’s membrane (Wilson and Hong, 2000). The stromal-
epithelial crosstalk is the most thoroughly characterized set of cell interactions in the cornea, 
as evidenced by the greater amount of research attention and publication it has received over 
the last few years. 
 
1.3. The Bowman layer 
The Bowman layer is a condensed acellular layer of collagen fibres. The layer presents a 
smooth interface to the epithelia, to which epithelial cells adhere, and a less distinct posterior 
surface that merges into the stromal collagen. Unmyelinated nerves penetrate into the 
Bowman layer to then innervate the epithelium (Lagali et al., 2009). The exact purpose of the 
Bowman layer is unclear although it shows clear difference from stromal collagen. The layer 
seems to function as an intermediate “ligament” between the protective epithelium and the 
structural stroma. Congenital absence of the Bowman layer does not seem to be associated 
with otherwise abnormal or hazy corneas and the layer is in fact absent in some species 
(Wilson and Hong, 2000). The layer itself is only around 12μm thick and, if damaged, isn’t 





The stroma’s complex network of hydrated extracellular matrix (Fujii et al., 2015) makes up 
over 80% of the cornea’s total volume. The tissue is composed of interwoven fibrous proteins, 
mainly collagens type I and V. Binding the fibres together are glycosaminoglycans such as 
chondroitin, dermatan, keratan, and heparan sulphates (Pacella et al., 2015). These 
glycosaminoglycans have many roles: they regulate hydration, arrange fibre distance, bind 
cytokines and cations, and support structural integrity (Fini and Stramer, 2005). The collagen 
fibrils in the human cornea are highly organized and tightly packed into bundles called 
lamellae (Smith and Frame, 1969). These lamellae were arranged parallel to the corneal 
surface and were interwoven with adjacent lamellae. In the anterior part of the cornea, the 
fibres undergo a high degree of interweaving, forming a compact fibrillar network. At the 
stroma’s posterior, the lamellae undergo less splitting and less interweaving, these features 
coincide with a lower concentration of cells and increased swelling properties (Komai and 
Ushiki, 1991, Mikula et al., 2018). The parallel alignment of the collagen fibrils within the 
lamellae contributes to the cornea’s transparency; the strands of collagen are woven and 
spaced by glycosaminoglycans and other collagen types. This results in a local order forming 
a pseudo-crystalline structure that facilitates the passage of light through the cornea (Maurice, 
1957). The concentrations and distributions of glycosaminoglycans in the corneal stroma vary 
along the anterior-posterior gradient. This results in parts of the corneal stroma reacting to 
stress and swelling differently (Muller et al., 2001).  
  
1.5. Descemet’s membrane 
There exists another acellular membrane in the cornea, made up of multiple types of collagen. 
This membrane, called Descemet’s membrane, is made and maintained by the endothelial 
cells. This membrane seems to be a physical barrier against infections and infiltration as well 
as the basal structure to which the endothelium adheres (Hayashi et al., 2002b). Impairment to 
Descemet’s membrane through infections, wounds or the hereditary conditions known as 
Fuchs’s corneal dystrophy can lead to corneal thickening and cloudiness (Siggel et al., 2019).  
 
1.6. Endothelium 
The final layer of the cornea positioned on the posterior side of the Descemet’s membrane 
and separating the cornea from the aqueous humour is the endothelium. This is an avascular, 
single layer of hexagonal cells. While interactions between the endothelium cells and stromal 
keratocytes have been the subject of relatively little investigation, the principal function of the 
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endothelium has been documented as being active transport of water out from the stroma into 
the anterior chamber of the eye using ATPase pumps (Tuft and Coster, 1990). This movement 
of fluids prevents stromal swelling and opacity, maintaining transparency. The endothelium 
also traffics glucose and other essential nutrients into the stroma to feed the cell within 
(Adamis et al., 1993). Whilst it is known that endothelial cells produce modulatory cytokines 
such as interleukin 18 and platelet-derived growth factor 7, the exact nature of any 
biochemical signal exchanged between stromal cells and endothelial cells is unknown (Kim et 
al., 1999).  
 
2. Keratocytes 
Within the stroma, between the collagen lamellae, reside the cells thought responsible for the 
construction and maintenance of the stromal tissue. These cells are the keratocytes. Typically 
quiescent and evenly spaced out, these cells will become active in response to injury and 
slowly repair the specialized ECM (Jester et al., 1999). While fibroblastic in nature, the 
keratocytes do possess some traits that make them unique, like their crystalline-rich 
cytoplasm (Jester, 2008). The majority of these keratocytes are positioned in the anterior 
portion of the cornea, near the epithelium and nerves as well as where injury is most likely to 
occur (Poole et al., 2003).  
 
2.1. Keratocytes during morphogenesis 
The mammalian eye is constructed during development from the neural crest, itself yielding 
three sources of precursor eye cells: neural ectoderm, surface ectoderm and periocular 
mesenchyme (Williams and Bohnsack, 2015, Gage et al., 2005). The periocular mesenchyme 
specifically will derive the stromal cells that maintain the construct the stroma and will later 
become keratocytes (Yoshida et al., 2006). The cells in the periocular mesenchyme initially 
build and remodel ECM into stroma, with its unique structure and deposited proteins that 
make it transparent (Quantock et al., 2003). As the tissue takes form, the cells will undergo 
apoptosis and the small population that remains will express proteins key to corneal stromal 
cell function, like crystallins (Jester, 2008). The differentiation from neural crest cell into the 
quiescent keratocyte can be traced using the disappearance of PAX6, a marker of early eye 
development, and appearance of CD34, a general marker of mesenchymal stem cells 
(Funderburgh et al., 2005). Expression of CD34 does decrease when the quiescent keratocytes 
become activated in the event of an injury (Funderburgh et al., 2003). This loss of expression 
 9 
is particularly evident in vitro where CD34 expression disappears almost entirely upon 
keratocyte activation (Toti et al., 2002a). 
 
2.2. Homeostasis 
The specialized form of fibroblasts, called keratocytes, are normally found embedded within 
the stromal ECM in a quiescent state, becoming activated as a response to any disruption to 
the stroma such as trauma or infection. The activation process is mediated by growth factors 
like TGFβ, FGF and PDGF (Ljubimov and Saghizadeh, 2015). The majority of these 
quiescent keratocytes reside in the anterior portion of the stroma, closest to the epithelium. 
The adjacent epithelium provides the stroma and the cells within with growth factors, such as 
hepatocyte growth factor (HGF) and keratinocyte growth factor (KGF) (Wilson et al., 1999, 
Reinach and Pokorny, 2008). As with almost every cell population in the body, there needs to 
be a stock of progenitor cells to maintain a large enough population of functional cells. For 
the corneal stromal cells, this population is found in the limbus. Analysis of CD34 expression 
in particular shows that the limbus hosts a greater percentage of CD34 positive stromal cells 
(Branch et al., 2012). 
 
2.3. Wound healing 
During wounding, replacement of lost keratocytes requires activation of nearby keratocytes; 
this active state is characterized by a change in morphology to more typically fibroblastic 
traits like a larger spindle-like shape, increased organelle content and a loss of cytoplasmic 
granules (Fini and Stramer, 2005). This is in contrast to normal keratocyte morphology where 
quiescent cells are stellate or dendritic with a triangular body (Espana et al., 2003). The newly 
activated cells then migrate into the wound area and remodel the ECM with matrix-degrading 
enzymes and new matrix components. The fibroblasts also express smooth-muscle actin and 
desmin, becoming contractile to stimulate wound closure (Chaurasia et al., 2009). 
Activated keratocytes lose expression of proteins associated with cellular transparency such 
as ALDH1A1 and crystallins (Jester et al., 1999). Activated keratocytes may also become 
myofibroblasts and express alpha smooth muscle actin (αSMA). These terminally 
differentiated, contractile cells are typically found only at wound sites to aid in closure by 
enlarging and spreading. Myofibroblasts will also produce some ECM crosslinkers and 
MMPs to remodel damaged stroma (Ebihara et al., 2007). While the myofibroblasts and 
fibroblasts play an essential role in wound healing of the cornea, persistence of these 
differentiated cell states are also associated with multiple pathological processes like corneal 
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haze and scarring (Connon et al., 2003). Studies into the behaviour of stromal cells during 
surgical wound events found that stromal cells near the wound would differentiate into 
myofibroblasts, resulting in a fibrotic haze, The fibrous matrix would resolve itself into a 
more transparent matrix over the two following months as the myofibroblasts were replaced 
with the quiescent keratocytes (Kivanany et al., 2018). Conserving the undifferentiated state 
of stromal keratocytes until fibroblastic differentiation is required as a vital role of signalling 
factors in the stroma. 
 
3. Keratoconus 
3.1. Incidence and associated factors 
An estimated 1 in 2000 individuals is affected by keratoconus with varying degrees of 
severity. Keratoconus’ onset is typically observed and initially diagnosed between the ages of 
15 and 25. A steady decline in the incidence of the disease is observed with age, likely due to 
tissue stiffening making the hallmark corneal deformation less likely. The disease has a higher 
reported prevalence in males, with around 60% of cases occurring in males (Godefrooij et al., 
2017). Initial reports on keratoconus observed that the disease seemed to affects all ethnic 
groups equally. However, a significantly increased incidence was later reported for patients of 
middle-eastern and north African descents. In a retrospective study, North-Pakistani, Iranian 
and Saudi Arabian ethnicities in particular were identified as groups particularly at risk of 
developing keratoconus (Georgiou et al., 2004, Ziaei et al., 2012, Assiri et al., 2005). The 
high incidence of consanguineous marriages has been proposed as a likely cause for the 
increased occurrence of keratoconus among these groups (Assiri et al., 2005). The occurrence 
of keratoconus in some patients may sometimes coincide with other systemic diseases, such 
as Down’s syndrome and Leber’s congenital amaurosis (Elder, 1994, Rochels, 1979, Cullen 
and Butler, 1963). However, no conclusive genetic link has been established between 
keratoconus and these other conditions. It should also be taken into account that any disease 
or habit that results in excessive eye rubbing, such as atopy or wearing of hard contact lenses, 
could exacerbate pre-existing keratoconus into manifesting diagnostic signs (Wang et al., 
2000). Keratoconus may initially weaken or deform the cornea, allowing further mechanical 
or inflammatory stress to worsen the condition and accelerate the need for treatment.  
 
The genetic presentation associated with keratoconus shows great variance. Genetic and 
epigenetic factors are likely at fault and in some case have been found to associate with 
specific ethnic groups at times. Large-scale genetic studies of keratoconus may be impeded by 
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small sample sizes and catchment areas as well as some variation in disease presentation. This 
leads to varying reports in genes associated with keratoconus. Undertaking large-scale 
cooperative efforts in genomic studies would no doubt aid in understanding keratoconus 
genetically, particularly in Southern Asia where the disease is currently most present (Kok et 
al., 2012). Some candidate genes have already been identified in relation keratoconus 
pathogenesis due to their reoccurrence across several studies and patient groups. Genes like: 
Visual system homeobox 1 (VSX1), superoxide dismutase 1 (SOD1) and lysyl oxidase (LOX) 
all have documented evidence of mutations being associated with increased keratoconus 
susceptibility (Gordon-Shaag et al., 2015, Zhang et al., 2015). 
 
3.2. Pathophysiology and molecular signalling 
Stromal thinning is seen in all cases of keratoconus and multiple factors are to blame. An 
increase matrix degradation by proteolytic enzymes would break down the collagen while a 
drop in stromal cell population would delay replacement of lost extracellular matrix (ECM) 
(Romero-Jimenez et al., 2010).  As a consequence of this ECM structural weakening, the 
mechanical properties of the matrix would be altered, providing new cues to differentiating 
keratocytes and progenitor cells. More severe stromal deformation may also affect the 
epithelial cells that reside above. The epithelium may be partly lost due to excessive eye 
rubbing. Beyond providing some structural support to each other, epithelial cells and stromal 
cells also communicate via a multitude of secreted factors. The implications of this 
relationship between the two cell types is that, should one be damaged or lost, the other will 
likely be affected in some manner (Tsubota et al., 1995). While epithelial loss often affects 
the stroma in some manner, keratoconus has not been reported as always presenting thinned 
epithelium prior to loss of ECM or stromal cells.  
 
A common diagnostic sign of keratoconus is Fleischer’s ring. This is made of iron aggregated 
by ferritin, an intracellular iron storage protein and then deposited in the basal epithelium 
(Loh et al., 2009). Tear fluid is the likely source of the deposited iron as lactoferrin normally 
binds the iron in the tears. A hypothesis of “tear-pooling” has been proposed where the 
collection of tears along the lines of lid closure lead to repeated concentration of iron in 
specific location in the cornea. Altered iron metabolism may occur within keratoconic tissue. 
Iron is a required cofactor for the formation of amino acid hydrolysine, which is then used to 
regulate collagen fibre diameter. In keratoconic tissue, hydroxylysine content in particular is 
reportedly lower (Cannon and Foster, 1978); indicating that iron metabolism may be 
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disrupted upstream although the exact pathway is unclear. There are no reports of the 
accumulated iron affecting cell behaviour either in the epithelium or the stroma.  
 
In the past, research has shown that keratoconus is a multifactorial disease with both genetic 
and environmental components at play. There is evidence that a genetic predisposition to the 
disease may exist, allowing environmental triggers to induce some inflammatory components 
(Galvis et al., 2015). While the magnitude of inflammation’s role in keratoconus remains 
uncertain, its involvement in some way has been documented as evident. Specific pro-
inflammatory factors have been identified in aberrant amounts, either at the gene or protein 
level, within the stroma and epithelium. This increased production undoubtedly causes stress 
to the cells within the stroma and nearby. Interleukin 1 (IL-1) is a family of 11 cytokines that 
regulate immune and inflammatory responses, particularly during corneal wound healing. IL-
1α and IL-1β are the main cytokines found during corneal injuries and both induce 
remodelling through apoptosis and MMP up-regulation. IL-1α is secreted by corneal 
epithelial cells and then diffuses both into the tear film and into the stroma (Wilson et al., 
1996). According to Bureau et al., IL-1α and IL-1β are both present in greater concentrations 
in the keratoconic stroma, and stromal fibroblasts also display elevated levels of IL-1α 
receptors on their surface (Bureau et al., 1993). It is also known that IL-1α and IL-1β can 
induce apoptosis in conjunction with tumour necrosis factor alpha (TNFα); therefore, the loss 
of keratocytes in keratoconic corneas is likely to be secondary to increased levels of IL-1 
within the stroma. Furthermore, IL-1 decreases production of superoxide scavenger SOD3, 
increases production of prostaglandin and increases production of MMPs (Balasubramanian et 
al., 2010). Those factors together would contribute to lower rates of cell survival, premature 
differentiation, stem cell depletion and matrix degradation, as seen in keratoconus. 
 
Interleukin 6 (IL-6) is a pro-inflammatory cytokine mainly expressed by T cells and 
macrophages. IL-1 stimulates production of IL-6 in order to amplify inflammatory signal and 
wound healing. While IL-6 is expressed in greater quantities in tears of patients with 
keratoconus, its level does not increase with disease severity. Instead, friction events such as 
eye rubbing and contact lens wear seem to have the greatest effect on IL-6 production 
(Balasubramanian et al., 2013). Ebihara et al., have shown that IL-6 activity will lead to 
typical wound healing events such as epithelial cell migration and vascularization via VEGF 
(Ebihara et al., 2011).  
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Specific MMPs such as gelatinase A (MMP2) and MMP14 were found to be more active in 
keratoconus corneas and are likely responsible for matrix degradation during disease 
progression (Collier, 2001, Davidson et al., 2014). The stroma is composed of stacked 
collagen fibrils cross-linked with proteoglycans and also contains dispersed keratocytes that 
are responsible for maintaining the surrounding ECM. Keratocytes normally produce 
additional collagen as well as breakdown collagen to maintain a specific functional 
architecture. Sivak and Fini among others have reported that the proteolytic enzymes 
responsible for this maintenance are the matrix metalloproteinases (MMP) (Sivak and Fini, 
2002). MMPs are a family of zinc endoproteinases that typically bind to ECM components as 
well as some cytokines and cell surface proteins. All MMPs possess three characteristics: zinc 
is required for activity, a collagen interacting function and the inhibition by endogenous tissue 
inhibitor of metalloproteinases (TIMP) (Nagase and Woessner, 1999).  Their activity is 
required for processes such as angiogenesis and inflammation but also for proteolytic 
activation of cytokines such as TNFα, an inflammatory factor, and transforming growth factor 
beta (TGFβ), a cell growth and proliferation factor (Gearing et al., 1994, Yu and 
Stamenkovic, 2000). In keratoconus, MMPs are overexpressed while TIMP presence is 
decreased (Ionescu et al., 2016). This means that ECM degradation is less restricted in 
keratoconic corneal tissue due to an imbalance in the MMP-to-TIMP ratio.  
 
Increased inflammatory activity and enzymatic digestion of ECM is caused by an increase in 
total activation and production of digestive enzymes. A loss of inhibitory control on matrix 
metalloproteinases and interleukins also sustains structurally damaging activity. In the cornea, 
Galectin-1 (Gal-1) and Galectin-3 (Gal-3) were identified as anti-inflammatory regulators by 
research done in models of conjunctivitis, uveitis and retinopathies (Romero et al., 2006, 
Mello et al., 2015). Although it was never used in a clinical therapy, administration of Gal-1 
to the cornea can reduce corneal opacity and lesions brought by virus-driven inflammation 
(Rajasagi et al., 2012). Exogenous Gal-3 has also been documented as a potent re-
epithelialization reagent in corneal healing assays on mice and monkeys, causing epithelial 
disorganization by increasing MMP-9 production to disrupt tight junctions and allow 
restructuring epithelia into an even sheet (Cao et al., 2002, Fujii et al., 2015). Both Gal-1 and 
Gal-2 have been documented at higher concentration in keratoconic corneas, although Gal-1 
has been found in greater concentration within the stroma while Gal-3 remains within 
epithelial cells and keratocytes. The greater amount of Gal-1 may be an effect rather than the 
cause of the disease itself. In the past keratoconus has been reported as an inflammatory 
disease and this data continues to support an inflammatory theory (Andrade et al., 2018). Of 
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note is that UV exposure, particularly that seen during CXL treatment, has shown to an 
increased Gal-1 expression and decrease overall interleukin and digestive enzyme presence in 
the cornea (Zanon Cde et al., 2015).  
 
TGFβs are a family of pleiotropic cytokines capable of binding to multiple ligands with 
varying affinities. In severe keratoconus, elevated presence of TGFβ2 was noted (Priyadarsini 
et al., 2015). TGFβ2 is the main TGFβ isoform found in aqueous humour, and may have 
increased presence due to infiltrations. Increased αSMA has been linked to differentiation of 
keratocyte progenitor populations into myofibroblastic cells incapable of completely 
supporting the cornea (Engler et al., 2011). TGFβ is a versatile cytokine that possesses three 
isoforms (TGFβ1, TGFβ2, TGFβ3) and is typically involved in induction of genes responsible 
for differentiation, proliferation and migration. TGFβ also plays multiple roles in wound 
healing, acting as a chemoattractant for macrophages and fibroblasts (Amento and Beck, 
1991).  In the cornea, TGFβ is secreted by epithelial cells and diffuses into the stroma to bind 
to TGFβ receptors on keratocytes. The basement membrane between the epithelia and stroma 
acts as a potential barrier for TGFβ, however when the basement membrane is broken or 
damaged, TGFβ can pass into the stroma and induce fibroblastic differentiation in keratocytes 
to increase secretion of ECM at injury sites (Wilson, 2012). Additionally, TGFβ will maintain 
fibroblast viability in the presence of pro-apoptotic factor IL-1 with consequent stromal 
opacity.  TGFβ may also induce some stromal cells to enter a myofibrogenic state, 
characterized by the marker α smooth muscle actin (αSMA), where unaligned deposition of 
fibres leads to a more opaque ECM. The secretion of TGFβ1 by myofibroblasts was also 
found to inhibit the re-innervation of corneal tissue following injury via the phosphorylation 
of collapsing response mediating protein 2 (Jeon et al., 2018). 
 
 
There is evidence that different TGFβ isoforms can drive different matrix-producing 
behaviours. Particularly TGFβ3 was found to stimulate a higher degree of matrix alignment 
and little collagen type 3 or αSMA production. TGFβ1 and 2 on the other hand, lead to 
increased collagen type 3 and αSMA production (Karamichos et al., 2011). This suggests that 
TGFβ3 triggers different pathways of ECM production and is capable of driving the 
construction of clearer ECM. A decrease in matrix contraction was observed in keratoconic 
stromal cell culture and was rescued to healthy stromal fibroblasts levels with the addition of 
TGFβ isoforms (Lyon et al., 2015).  
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The multiple isoforms of TGFβ interact with multiple receptors and matrix ligands with 
varying affinities. TGFβ binds with high affinity to transmembrane receptor II and receptor I 
to form a heteromeric complex (Wrana et al., 1992). The receptor complex then 
phosphorylates receptor-regulated SMADs and binds the intracellular SMAD complex that 
will then act as a transcription factor and modulate gene expression (Otten et al., 2010). TGFβ 
also binds with matrix molecules like decorin. This binding allows for the neutralization of 
TGFβ and a mode of control over is bioactivity as the degradation of decorin allows for the 
release of TGFβ (Jarvelainen et al., 2015). The loss of decorin and general degradation of 
ECM in the keratoconic cornea impacts the regulation of TGFβ, although the full extent of 
this dysregulation isn’t documented. 
 
A significant link has been established between an HGF gene polymorphism and keratoconus, 
suggesting that the growth factor is implicated in the corneal deformation. Hepatocyte growth 
factor (HGF) and keratinocyte growth factor (KGF) are secreted by stromal keratocytes while 
the receptors to both factors are present on epithelial and stromal cells (Yu et al., 2010). Both 
factors are secreted in greater quantities following corneal epithelial wounding and increase 
the proliferation of epithelial cells. KGF receptors are present in stromal cells, but are 
concentrated at the limbal region where stromal progenitors may reside (Weng et al., 1997). 
HGF receptors are also present on stromal cells, although the expression of both the receptor 
and HGF itself are highest at the centre of the cornea (Li and Tseng, 1997). The distribution 
of c-Met and HGF are also affected in keratoconus, becoming less uniform and showing 
increased presence in the basal epithelia near the cone (You et al., 2015). The exact effect of 
HGF and KGF on stromal cells is still unknown due to inconclusive reported evidence 
(Carrington and Boulton, 2005). Although, no concrete pathway has been established, it has 
been speculated that IL-6 may be involved (Sahebjada et al., 2014).   
 
In keratoconic cells, a significant decrease in ALDH3 activity leaves the tissue more 
vulnerable to oxidative damage (Gondhowiardjo et al., 1993). This loss of protection may be 
the reason why stromal cells experience a decrease in population. The cornea is a transparent 
physical barrier that separates the eye from the environment. As such the cornea is normally 
exposed to a multitude of stress factors, particularly UV light. In addition, UV light 
irradiation stimulates production of reactive oxygen species (Mazzotta et al.) that 
consequently damage proteins or DNA, that may lead to mutations or cell autophagic 
malfunction (Heck et al., 2003, Shetty et al., 2017). DNA damage is particularly harmful to 
cells with a slower turnover rate as mutations are more likely to accumulate (Zierhut et al., 
 16 
2008). This is the case with stromal cells but not epithelial cells. While visible light must be 
able to transit through the cornea and into the eye itself, UV light penetration must be 
minimized to prevent damage to the retina. To protect the eye from UV light radiation, the 
cornea mass-produces an isoenzyme of aldehyde dehydrogenase (ALDH3) that acts as a filter 
to minimize penetration into the eye (Vallabh et al., 2017).  
 
Depending on the species, ALDH3 constitutes 5% to 50% of the total soluble proteins found 
in the cornea (Pappa et al., 2003). ALDH3 is found highly expressed in the corneas of most 
mammals with notable exception in rabbits (Piatigorsky, 1998). In the cornea, ALDH3 is 
strongly expressed on epithelial cells and stromal keratocytes but not in endothelial cells. 
ALDH3 is part of a protein group called crystallins, that is a lens and corneal proteins that 
make up a large percentage of water-soluble cell components. ALDH3 also protects cells 
from oxidative damage by aldehydes. The loss of ALDH3 prevents keratocytes from 
surviving UV radiation exposure.  
 
In keratoconus, the behaviour of the keratocytes is abnormal, with higher rates of cell death 
and loss of ECM that could be attributed to an imbalance in the signalling at molecular level 
from the epithelial cells, which may then be exacerbated by environmental factors or 
complications such as ruptures in Descemet’s membranes and Bowman layer isolating the 
stroma.  Breaks may then lead to infiltrations of neighbouring tissue fluids, such as aqueous 
humour or tear fluid. Direct contact between the epithelia and stroma may cause long-term 
wound-like signalling in the stroma. The underlying cause of keratoconus and the large 
mechanisms that connect the variety of molecular imbalances seen in the disease remain to be 
fully elucidated. While treatment options currently available have proven effective, current 
research into keratoconus at the molecular level has been significant and has shown important 
progress aiming to establishing a detailed understanding of keratoconus as well as leading to 
novel therapies. 
 
3.3. Diagnosis and treatment 
Keratoconus can present with some variable symptoms that change as the disease progresses. 
The initial symptoms typically include: loss of vision, glare, and distortion of vision among 
others. Structurally, a common feature of keratoconus is a thinning of the inferior and nasal 
portions of the corneal stroma. Keratoconus with the cornea protruding conically and an 
epithelial iron line called Fleisher’s ring partially surrounding the base of the cone. The 
degrees of tissue deformation can vary greatly between patients. Both the anterior and 
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posterior curvatures of the cornea are affected and tracking changes in the cornea’s shape over 
time is one of the most reliable diagnostic methods of identifying keratoconus and its 
progression (Schwiegerling, 1997, Tomidokoro et al., 2000).  
 
There are multiple characteristic clinical signs that can be used to set keratoconus apart from 
other ectatic conditions that affect the cornea (e.g. pellucid marginal degeneration) as well as 
determining severity of the disease (Sherwin and Brookes, 2004). These signals do not always 
occur but some combinations are typically observed. 
Clinical signs:  
1. Central and paracentral thinning of the cornea 
2. Vogt’s striae, vertical lines located in the superficial stromal layers that occur due to 
corneal deformation; 
3. Fleischer’s ring, an iron deposit in the basal epithelium that partially surrounds the base of 
the corneal cone; 
4. Epithelial thinning and a proud nebula, a small build-up of scar tissue at the very centre of 
the cornea that often results in some loss of vision; 
5.  Enlarged corneal nerves; 
6. Subepithelial fibrillary lines 
7. Stromal swelling due to break in Descemet’s membrane (i.e. Hydrops)  
8. Breaks in the central portion of the Bowman layer; 
9. Munson’s sign, a wedge-shaped indentation of the lower eyelid by the cornea when patient 
is looking down. This is common in advanced cases of keratoconus and is due to the conical 
cornea pushing into the lower eyelid. 
 
As the severity of keratoconus can vary, so can the treatment. Milder, non-progressing cases 
of the disease can be managed with glasses or contact lenses to correct visual impairment. 
More advanced or faster progressing cases of keratoconus may require more sophisticated 
intervention. Cross-linking can be used to stiffen the cornea in earlier stages of disease, fixing 
the tissue in a shape where vision can still be corrected with glasses or contacts. Crosslinking 
uses riboflavin administration and non-damaging UV irradiation of the stroma (Spoerl et al., 
2007, Raiskup et al., 2015). It should be noted that UV irradiation from the crosslinking 
treatment has been shown to reduce the number of cells in the treated stroma. Cell numbers 
do recover in the following months (Mazzotta et al., 2007). In the event that keratoconus has 
reached a stage where vision can no longer be corrected due to great deformation, corneal scar 
or unstable gas permeable contact lens fitting, surgery is often recommended. Surgery will 
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usually involve corneal transplantation or intra-stromal corneal ring (ISCR) implantation to 
mechanically strengthen the damaged tissue and restore corneal shape as well as slowing, but 
not arresting, the ectasia (Rabinowitz, 1998, Vega-Estrada et al., 2015).  
 
As previously mentioned, if the disease is found to be progressing but not yet in a severe 
state, collagen cross-linking treatment is recommended to strengthen the cornea and prevent 
further deformation. It is well-known however that like most other tissues in humans, the 
human cornea naturally stiffens and cross-links its collagen matrix with age, therefore it is 
expected that natural cross linking could slow or even arrest the progression of keratoconus 
(Robins, 2007). If the cornea is incapable of compensating for keratoconus by naturally 
toughening the remaining stromal ECM, then UV cross linking treatment can aid in slowing 
disease process by hardening the collagen matrix (Snibson, 2010). The cross-linking 
treatment uses photosensitizing riboflavin drops in the stroma and exposes these to UV 
radiation, forming molecular links between the collagen fibres of existing matrix in the cornea 
(Wollensak et al., 2003). The effects of UV irradiation are multiple, there is a marked increase 
in crosslinking proteoglycans like lumican, mimecan and decorin as well as a decrease in 
MMPs, these added consequences of UV irradiation also aid in strengthening the ECM 
(Sharif et al., 2018). Pre-treating patient corneas with only UV has been shown to regress 
invasive lymphatic and blood vessels, reducing subsequent graft rejection (Hou et al., 2018). 
 
In cases of advanced keratoconus where contact lenses no longer fit or where scar tissue 
occupies a significant portion of the cornea affecting the visual axis, a corneal transplant also 
known as keratoplasty (i.e. penetrating or deep anterior lamellar) would be recommended 
(Jhanji et al., 2011). Following penetrating keratoplasty, 70% of patients develop keratometric 
astigmatism in the 10 years that followed suture removal with most cases occurring after 7 
years (de Toledo et al., 2003). The recurrence of keratoconus following deep anterior lamellar 
keratoplasty has not yet been fully investigated, although a case has been reported where 
signs of keratoconus re-emerged 49 months after surgery (Feizi et al., 2012). All of the 
current treatment options, from glasses to transplants, only address secondary deficiencies in 
the corneal structure rather than directly dealing with the primary pathogenic faults in cellular 
behaviour and molecular pathways. 
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4. Corneal tissue engineering  
4.1. Models of the stroma 
Modelling the cornea in vitro offers some unique opportunities when it comes to more closely 
studying cell interactions. In vitro models can use human cells and are far cheaper than animal 
or human studies. It should also be noted that the structure of the cornea varies across species 
with the thickness and existence of certain tissue layers found in the human cornea changing 
from among animal models. Cell culture models are normally the first step in any biological 
research. For the cornea and its stroma, multiple models have been constructed and used, 
from the very crude immortalised cell culture to more 3D culture of multiple primary cell 
types. Most of the recent work done on the cornea tends to focus on epithelial and stromal 
cells, often using collagen as a substrate. Ideally, the collagen matrix would be produced and 
maintained by the keratocytes as this would most closely resemble the natural matrix. 
However, this method of matrix production is time consuming, requiring many months to 
form a suitable piece of tissue (Gouveia et al., 2017). The use of collagen mimics the tissue 
the cells are typically found on or within and allows the cells to more easily manipulate their 
surroundings in long-term cultures (Reichl et al., 2004, Suuronen et al., 2004). Collagen as the 
substrate does have the limitation of low mechanical stiffness, but that could be overcome 
with compression (Roeder et al., 2002). Compressing the collagen increases the concentration 
of collagen fibres. Although the high density and geometry of a natural cornea still cannot be 
easily mimicked, simple compression provides an inexpensive method of approaching the 
stroma’s complexity. The compressed collagen gels may further resemble the stroma by 
incorporating specific thicknesses and curving (Miotto et al., 2019) 
 
4.2. Models of keratoconus 
Although a great amount of research has been undertaken investigating the etiology of 
keratoconus, the cause and disease pathways remain unclear (Maguire and Bourne, 1989). In 
the past, cultures of keratoconic stromal cells identified some differences with healthy stromal 
cells, particularly in regards to gene expression and protein secretion (Gouveia and Connon, 
2013). Critically, these in vitro studies aim to replicate the environment of the corneal stroma 
with supplements. Taken a step further, a model of keratoconus was a previously constructed 
using 3D scaffold to investigate the relevance of 3D culture on the modelling of keratoconus 
and cell behaviour (Karamichos et al., 2012). Although the culture in question used serum 
medium when investigating cell behaviour, convincing evidence showed that a 3D culture 
system might be more desirable if modelling keratoconus. 
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The aim of this study was to construct a 3D in vitro model of keratoconus. To the author’s 
knowledge, this is the first 3D in vitro model which use serum-free conditions, similar to the 
cornea’s own environment. This model was then be compared to several types of healthy 
stromal cells to better understand the disease identity. Ultimately, the development of such a 




Chapter 3: General Methodology 
1. Tissue Culture 
1.1. Stromal cell growth medium 
The base for the keratocyte expansion medium comprised of 500ml of 1:1 of Dulbecco’s 
modified Eagle medium and Ham’s F12 (DMEM/F12) (Gibco, UK). Added to the 
DMEM/F12 was 50ml of foetal bovine serum (FBS) (FBS; Gibco Invitrogen) and 5ml of 
100X Penicillin/Streptomycin (Invitrogen, UK). This expansion medium was used during cell 
extraction and expansion prior to experiments. 
 
1.2. Stromal cell serum-free medium 
Serum-free medium was used to assay cell survival and simulate the stromal environment. 
This medium also used 500ml of 1:1 of Dulbecco’s modified Eagle medium and Ham’s F12 
as a base. Added to the DMEM/ F12 was 5ml of 1X ITS liquid medium supplement (Sigma-
Aldrich), ascorbic acid (Sigma- Aldrich) to a concentration of 10μM and 5ml of 
penicillin/streptomycin (Invitrogen) for a final concentration of 50 units/mL of penicillin and 
50 μl/mL of streptomycin. 
 
1.3. Preparation of retinoic acid aliquots and addition to cell cultures 
3 mg retinoic acid (RA) powder (Merck, USA) was solubilized in 10mL of absolute ethanol 
to produce a 1mM stock solution, which was sterile-filtered and stored in aliquots at −80°C 
for up to 1 month. RA was added to serum-free medium immediately before use by diluting at 
a ratio of 1:1000 medium volume for a final concentration of 1μM. While addition of RA to 
cells cultured on plastic had some positive effects, addition of the same concentration of RA 
to collagen gel cultures proved toxic. After serial dilution of RA, it was found that halving the 
concentration to 0.5μM had the most positive effect on cell in gels while 1μM still had the 
most positive effect for flat culture on plastic. A different concentration of RA was therefore 
used for each situation. 
 
1.4. Stromal cell culture  
Extracted cells were seeded into tissue culture plastic vented flasks at an approximate density 
of 500 cells per cm2 in an appropriate amount of growth medium. The flasks containing cells 
were left in an incubator (37°C, 5% CO2, 100% humidity) so that the cells may adhere. 
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Medium was then replaced every 2-3 days until a confluence of around 80% could be seen 
under a bright field microscope. Cell passaging began with removing the medium and gently 
washing the cell monolayer with 1X PBS. A solution of 0.5% trypsin/EDTA (Invitrogen, UK) 
was then added to the cells and the flask was returned to the incubator for 5 minutes, the 
amount added was enough to cover the cells. After incubation, the flask was observed under a 
brightfield microscope to ensure cells had detached. If an insufficient number of cells had 
detached, gentle tapping or an extra minute of incubation was used to dislodge the cells 
further. To partially neutralize the trypsin, an equal volume of growth medium containing 
FBS was added to the flask and then washed 2 to 3 times over the culture surface to suspend 
the cells in the liquid. The cell suspension was then transferred in its entirety to an appropriate 
centrifuge tube and centrifuged for 5 minutes at 600G to pellet the cells. The supernatant was 
gently removed to avoid disturbing the pellet. The pelleted cells were resuspended in 1mL of 
growth medium for counting. Cell number was determined using the Countess II FL Cell 
Counter (Invitrogen, UK), 10μl of cell suspension was mixed with 10μl of 0.1% trypan blue 
solution in a small Eppendorf tube. 10μl of the cell-dye mix was added to the chamber of a 
haemocytometer slide and inserted into the machine. The image was used to determine if any 
large debris was present and live/dead ratio was determined automatically with the count. 
 
1.5. Stroma enzyme digestion 
The study was carried out in accordance with the principles of the Declaration of Helsinki. 
Whole donor corneas were supplied by NHSBT Manchester Eye Bank in the UK, under a 
tissue supply agreement for research and met internationally recognised standards. All 
patients gave general consent to participate in the study and to have the procedures carried out 
(donor ages: 69, 80, and another 80; all female with no prior history of corneal diseases or 
ocular trauma). Prior to cell extraction, the corneas were suspended in dextran-containing 
medium and stored at hypothermic conditions for several weeks.  
The corneal centre of whole corneas was isolated using a biopsy punch (diameter=0.8cm). 
The isolated central and limbal corneal stroma were separately minced using a scalpel. The 
limbal tissue was solubilized using collagenase digestion [growth medium with 2 g/L (450 
units/ml) collagenase type-1 (Invitrogen)] for 5 hours under continuous rotation at 37°C. 
Initially, no cells could be recovered from the central button when using the same digestion 
technique as limbal rings. A shorter digestion time of 2h30 proved effective in yielding cells, 
potentially due to the smaller amount of collagen or more sensitive cells. The isolated 
keratocytes were initially cultured in tissue culture flasks, fed every two days with growth 
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medium until reaching 70-80% confluence. Cells were then passaged and further expanded 
until a high enough population was reached for experimentation.  
 
1.6. Stromal explant migration 
The study was carried out in accordance with the principles of the Declaration of Helsinki. 
Whole donor corneas were supplied by NHSBT Manchester Eye Bank in the UK, under a 
tissue supply agreement for research and met internationally recognised standards. All 
patients gave general consent to participate in the study and to have the procedures carried out 
(donor ages: 69, 80, and another 80; all female with no prior history of corneal diseases or 
ocular trauma). Prior to cell extraction, the corneas were suspended in dextran-containing 
medium and stored at hypothermic conditions for several weeks.  
The corneal centre was isolated using a biopsy punch (diameter=0.8cm). The separated 
central stroma and limbal stroma were each separately minced using a scalpel into 
approximately 1mm3 pieces and put into a 12 well plate (4-6 pieces per well). The cornea 
pieces were then left to dry for 10 minutes in a tissue culture plate until adhered to the plastic. 
Keratocytes were left to migrate out of the explants in growth medium for 10 to 14 days until 
70-80% confluence. Cells were then passaged and further expanded until a high enough 
population was reached for experimentation.  
Any remaining tissue pieces were set aside and underwent enzyme digestion as previously 
detailed to extract any cells still inside the explant. The “resident” cell population digested out 
of the explants was then passaged and further expanded until a high enough population was 
reached for experimentation. 
 
1.7. Keratoconic cell sources 
Keratoconic fibroblasts (KF), isolated from human keratoconic corneas (n = 3; courtesy of Dr 
Dimitrios Karamichos, USA) were maintained using growth medium. The frozen cells were 
shipped to the UK in aliquots of 1x106 cells/mL and stored in liquid nitrogen upon arrival. 
Upon thawing, the cells were then passaged and further expanded until a high enough 
population was reached for experimentation. Patient data could not be obtained, and it is 
assumed that the keratoconic tissue was sourced from a graft procedure where the disease 
severity required intervention. Previous studies on the demographics of keratoconus (Rafati et 
al.,2019) suggest that the donors where likely between the ages of 20 and 30, younger than 
the on-average 75-year-old healthy donors used here. There is also a slightly larger male 
population with keratoconus, meaning that the donors could be mostly male. As all the 
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healthy donors used here were older female, this adds two important points to consider when 
comparing the behaviour of the two cell types. Whether scar tissue was present on the tissue 
when the cells were extracted is also unknown. 
 
1.8. Freezing and thawing stromal cells 
All the previously described cells underwent liquid nitrogen storage for a period of time to 
maintain a low passage number over the course of experiments. Freezing the cells involved 
initially detaching and counting the cells as previously described. Cells were then 
resuspended in an appropriate volume of growth medium and distributed into specialized 
cryovial, each filled with 1 million cells in a mixture of 700μl growth medium, 200μl FBS 
and 100μl DMSO. The vials were then tightly sealed and placed in a foam vial holder. The 
vial holder was left to cool overnight in a -80°C freezer before the tubes were finally 
transferred to the liquid nitrogen storage units. Thawing involved retrieving the tubes from the 
liquid nitrogen and placing them in a water bath at 37°C, taking care not to fully submerge the 
neck of the vial to avoid contamination. The thawed contents of the tubes were then 
resuspended in growth medium and the cells seeded at an approximate density of 5000 
cell/cm2. The cells in the flask were allowed to adhere for up to 5 hours before gently 
replacing the medium to remove any DMSO leftover from freezing. The morphology of the 
cells was monitored to ensure freezing had not damaged the cells and no contamination had 
occurred. 
 
1.9. Culturing cells serum-free conditions 
Cells used for experiments were first grown to approximately 80% confluence in growth 
medium. The growth medium was then substituted for serum-free medium in order to 
eliminate the serum from the cells. After the 3 days of serum-starvation, the cells were 
detached and counted. The cells were resuspended in an appropriate amount of serum-free 
medium and then seeded at a density of 100000 cells per cm2 in a 24 well plate. Medium used 
to feed the cells was either serum-free medium or serum-free medium supplemented with 
retinoic acid at a concentration of 10μM. The cells were inspected regularly for any signs of 
contamination or anomalous development. 
 
1.10. Culturing cells in compressed collagen gels 
Ice-cold rat-tail collagen type I (2 g/L in 0.6% acetic acid; First Link Ltd, UK) was mixed 
with 10x Modified Essential Medium (Life Technologies, USA) and neutralised with 1M 
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NaOH at a 1:7:1 volume ratio. Cells suspended in serum free medium were then added at to 
the gel mix to a final concentration of 100,000 cells/ml. A millilitre of cold gel mix was 
pipetted a 24 well-plate wells and allowed to solidify at 37°C for up to 1h. Absorbent inserts 
(Lonza, Switzerland) were applied to the gel-containing wells and left to compress the gels 
into thin discs of collagen with a diameter of 15mm and thickness of around 100 microns. 
Compression took approximately 5 minutes. The resulting compressed collagen gels (CCG) 
were cultured in serum-free medium on either flat plastic (Fig. 1) or pinned by a metal ring 
onto a spherical glass cap (Fig. 2). Medium used to feed the cells was either serum-free 
medium or serum-free medium supplemented with retinoic acid at a concentration of 0.5μM. 
The cells were inspected regularly for any signs of contamination or anomalous development. 
 
Figure 3: Preparation of compressed collagen gels. A solution of liquid collagen with stromal 
cells suspended within is initially pipetted into an empty well of a 24 well plate and left to 
solidify. The specialized absorber was then gently placed onto the solid collagen and allowed 
to compress the gel. After compression, a thin disc of collagen with stromal cells embedded 








Figure 4: Preparation of compressed collagen gels and subsequent culture on a glass dome 
pinned by a metal washer to simulate the curvature of the corneal stroma.  
 
2. Assays and Analysis  
2.1. Alamar blue: Resazurin fluorescence to count cells 
The Alamar blue assay is a primarily metabolic assay that relies of the mitochondrial 
reduction of resazurin salt to resofurin. Resazurin is not fluorescent but resofurin is and the 
progressive shift from one to the other is characterized by culture medium shifting from a 
deep blue to a purple-pink colour. Quantification of this fluorescence gives a reliable measure 
of the metabolism of a cell population and therefore, through a standard curve, the total 
number of cells in a well. A stock solution of 0.5mM resazurin salt was prepared in serum-
free medium and kept at 8°C for up to two months. When needed, the stock solution would be 
diluted in a 1:10 working solution in more serum-free medium and used to replace the cell 
culture medium. 
A standard curve had to be prepared for each of the 7 cell types and 2 culture methods 
assayed throughout this experiment. To make a standard curve, a large number of cells were 
initially serum starved, detached and counted before seeding into a 24 well plate in increasing 
amounts. The highest number of cells seeded in a well was 300000 cells while the lowest 
amount was 1000 cells; a blank well was also used. These cells were allowed to adhere for 3 
hours before very gently removing the medium they were seeded in, via a pipette, and 
replacing it with 250μl Alamar blue working solution. The cells were returned to the 
incubator for 1h30, by then a colour change was visible with the solution showing a pink-blue 
gradient correlated with the number of cells seeded. 100μl of the culture supernatant was 






then transferred to a Varioskan LUX multimode microplate reader (ThermoFischer, Franklin, 
MA) where the supernatant was exposed to a laser at 545nm and fluorescent emission 
intensity was measured at 580nm. This allowed for the correlation of fluorescent values to 
population number for each cell type via a standard curve and the slope equation that 
described the fluorescence/cell-number relationship mathematically. The Alamar blue
 
assay 
was used to assess keratocyte proliferation and viability in serum-free medium over a period 
of 11 days for flat plastic cultures and 30 days for CCG cultures. 
 
2.2. Reverse Transcription Polymerase Chain Reaction 
The polymerase chain reaction (PCR) is a method that exponentially amplifies copies of DNA 
to generate a high number of a specific DNA sequence. This method allows for the 
determination of individual transcripts for specific cells. PCR uses cycles of denaturation to 
expose the DNA base, annealing to attach primers, and extension by high-temperature TAQ 
polymerase. The TAQ polymerase synthesizes a matching DNA strand by using the primer-
binding site as a site of initial activity. PCR can also be used on the less-stable, single-
stranded RNA. In order to do that, total RNA was first extracted and purified. In this study, 
two methods were used for RNA extraction, these methods are detailed in the next two 
sections. 
 
2.3. RNA extraction from adherent cells 
Cells cultured on plastic proved simplest to extract RNA from. First, medium was removed 
from the cells and the monolayer was washed with PBS. Then, the cells were detached and 
centrifuged as previously described in the passaging methodology. The RNeasy kit (Qiagen, 
UK) provides a lysis buffer that can easily break down the cells once they have been detached 
and centrifuged into a pellet. Once the supernatant was carefully removed, 350μl of RLT 
buffer was added. An equal volume of 70% ethanol was added to the now dissolved pellet of 
lysed cells, this precipitates the nucleic acid content of the lysate mix. The 700μl mixture was 
transferred to the upper chamber of an RNeasy spin-column and centrifuged at 8000G for 15 
seconds; the resulting flow through was discarded. This caused the precipitated nucleic acid, 
DNA and RNA, to bind to the column’s silica membrane. 
The columns were then washed with 700μl of the kit’s RW1 buffer to remove carbohydrates, 
proteins and fatty acids that may have adhered non-specifically to the membrane. The column 
was once again centrifuged at 8000G for 15 seconds. The columns were then washed with 
500μl of the kit’s RPE buffer twice, with the first centrifugation lasting 15 seconds and the 
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second centrifugation lasting 1 minute. This step removed traces of salts from the column. 
The column was then transferred into a new collection tube and centrifuged at maximum 
speed to dry the membrane. 35μl of RNAse-free water was added to the centre of the 
membrane and allowed to soak for 1 minute. The column was then transferred to a final 
collection tube and centrifuged at 8000G for 1 minute. The final product was 35μl of DNA 
and RNA from the stromal cells. 
RNA purity was assayed using a Nanodrop 2000 spectrophotometer (Thermo Scientific, UK) 
by loading 1μl of the extracted RNA mix to the pedestal. The purity was determined by an 
A260/A280 ratio within the range of 1.7 to 2.0 and an A260/A280 above 2:1. Concentration had to 
be above 75ng/μl for use in later assays. The purified RNA was then either immediately used 
to make cDNA or stored at -80°C. 
  
2.4. RNA extraction from cells in collagen gels  
Extracting RNA from cells cultured in CCG proved more difficult as the RLT buffer could 
not lyse the ECM to release the cells within, resulting in a clogged membrane in the RNeasy 
columns. Instead, a previous method that employs TRIZOL (Sigma-Aldrich, UK) to extract 
RNA from collagen-based constructs was used. 
Collagen gels were lifted from their plates and separately minced finely with a scalpel. Small 
portions of the minced gels were added to an Eppendorf tube filled with 1ml of TRIZOL. A 
syringe was used to pass the gel pieces through a 21G needle until the gel-TRIZOL 
suspension was suitably homogenized. The mix was then vortexed and inverted. The now 
homogenized and mixed cell lysate in TRIZOL had 200μl of chloroform added and was 
mixed by inversion for 30 seconds. The tube was left to incubate at room temperature for 15 
minutes to allow for some initial separation. The lysate was then centrifuged at 18000G for 15 
minutes at 4°C. This caused a separation of the lysate into three distinct phases: a bottom red 
phase of proteins and debris, a middle grey phase of DNA and an upper clear phase of RNA. 
The RNA phase was carefully removed and transferred to a new collection tube. An equal 
volume of 100% ethanol was added to the RNA and the RNeasy kit’s procedure detailed 
above could follow with the RW1 buffer, RPE buffer and column purifying the RNA further. 
Once the RNA was purified, purity and concentration were assayed as previously described 
using the Nanodrop. 
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2.5. Synthesis of complementary DNA 
The instability of RNA makes it unsuitable for long term storage and frequent handling. 
Synthesizing complementary DNA (cDNA) by using viral reverse transcriptase yields 
complementary strands of more stable genetic material for our assays. To do this, the 
commercially available RT2 First Strand kit was used (Qiagen, UK) with every step being 
done on ice to minimize the risks of RNA degradation. An initial 8μl of the purified RNA was 
added to a PCR tube along with 2μl of Buffer GE. The mix was then incubated for 5 minutes 
at 42°C before being returned to ice for a minute. This incubation eliminated the genomic 
DNA and left behind only the RNA for reverse transcription. To the RNA, the following 
reagents were then added: 4μl of 5X Buffer BC3, 3μl of RNase-free water, 2μl of RE3 
Reverse transcriptase mix and 1μl of Control P2 primer mix. The tube was then gently tapped 
to mix the contents and incubated at 37°C for 1 hour and then at 95°C for 5 minutes. 90μl of 
nuclease-free water was added to the mix to bring the final volume to 110μl of cDNA. 
Concentration and purity were then assayed as previously mentioned and the total volume 
was adjusted to bring the final concentration of cDNA to 100ng/μl. The diluted cDNA was 
stored at -20°C until needed. 
 
2.6. Primer design 
Genes of interest were selected based on previous research and literature; primers were 
designed for these genes according to a set of specifications. These specifications were 
appropriate binding temperatures, minimal complementary self-assembly and low GC-rich 
regions. Identification of the transcript of interest was done using the ENSBL genome 
browser (https://www.ensembl.org/). The Primer3 design software (https://primer3.org/) was 
used to design relevant primers from the exon data according to our specifications. These 
primers were 19-22bp long, had a melting temperature as close as possible to 60°C and a GC 
content below 55%. The designed primers were finally entered into the NCBI primer blast 
database (https://www.ncbi.nlm.nih.gov/tools/primer-blast/) to identify any potential off-
target products. The resulting primers that were used in the experiments are listed below. 
 
Gene Primers 5’ → 3’ 
Decorin 
 (DCN) 























Retinoic Acid Receptor A  
(Greenbaum et al.) 
F: AGTCCTCAGGCTACCACTAT 
R: CCTCCTTCTTCTTCTTGTTT 















R: CTGTAGGTGCGGGTGGAC  
















Table 1: Description of primers used in qPCR for keratocyte gene expression analysis. 
 
2.7. Quantitative PCR 
While traditional PCR can inform on whether a gene is being expressed or not, quantitative 
PCR (qPCR) can provide relative quantitative data related to the expression of genes of 
interest. The most common form of qPCR uses SYBR green; a commercially available dye 
that intercalates within double stranded DNA and when excited by blue light will emit a green 
fluorescence. As the amount of fluorescence is directly proportional to the amount of DNA, 
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monitoring fluorescence intensity as the PCR progress provides a powerful method of 
relatively quantifying the amount of expression of particular genes.  
With fluorescence and time being plotted, a threshold of detection is set based on a no-
template control. The number of doubling cycles required to reach that fluorescence threshold 
is called the “cycle threshold” or “Ct”. For example, comparing the Ct of a particular gene 
between two cell types: A and B may show that cell type A’s Ct preceded that of cell type B 
by 4 cycles. This means that cell type A contained 24= 16 times more of the template gene 
than cell type B. 
 
The binding efficiency of each primer was calculated by first serially diluting some of the 
cDNA. Reaction mix was then made from 7µl of 2x SYBR green mastermix (Qiagen, UK), 
2µl of forward/reverse primers and 5µl of cDNA for a total reaction volume of 14µl. Various 
concentrations of cDNA and their mix underwent the following cycles: 10 minutes 
denaturation at 95°C, followed by 40x cycles of 10 seconds at 95°C, 30 seconds at 60°C and 
15 seconds at 72°C. The qPCR reaction was carried out in the Eco Real-Time PCR System 
(Illumina, USA). This gave a range of Ct that could be correlated to known cDNA 
concentrations to determine primer efficiency. When plotted against each other, Ct and cDNA 
dilution factor gave a slope that could input into the following equation: 
 
𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (𝐸) = 10(−1/𝑠𝑙𝑜𝑝𝑒) − 1 
 
This efficiency correction was then used when applying the Pfaffl mathematical model to 
determine expression profiling (Fleige et al., 2006). The equation for Pfaffl model is 
expressed below: 
𝐹𝑜𝑙𝑑 𝐶ℎ𝑎𝑛𝑔𝑒 =  
(𝐸𝑡𝑎𝑟𝑔𝑒𝑡 𝑔𝑒𝑛𝑒)





Negative controls were also done for each primer to account for any baseline fluorescence. 
Negative controls were also performed for each DNA sample with a reagent mix that 
contained no fluorophore to account for background fluorescence. No positive controls were 
used for any of the primers, although all primers did manage to detect their gene of interest in 
some samples. A potential weakness of the experimental design discussed above is the lake of 
inter-run calibration. This makes comparison between samples read in different plates weaker, 
despite the biological repeats. Any differences seen may be due to non-uniform heating of the 
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metal block, variable reagent reactivity, or fluorometric detector wear over time. Further 
experiments should aim to control inter-run variation by randomly assigning samples to 
plates.  
 
2.8. Statistical Analysis 
Statistical analysis was carried out using Graphpad Prism 6 (La Jolla, USA). Statistical tests 
were deemed significant when returning a p value of <0.05. All error bars presented are the 
standard error of the mean. When assessing the qPCR gene expression data, a one-way 
ANOVA was used with a post-hoc Dunnett’s test to correct for multiple significances. When 
assessing the cell survival data in serum-free conditions, two-way ANOVA was used with a 
post-hoc Bonferroni’s test to correct for multiple significances. The interaction p-value of the 
compared sets of survival data was reported and individual comparisons were made within 
timepoints; these individual comparisons are reported within the graphs. Significant 
differences are denoted within graphs with asterisk (* for p<0.05, ** for p<0.005, *** 




Chapter 4: Isolation of stromal cells from different parts of the cornea 
1. Abstract 
Current research on healthy corneal stromal cells will typically use primary cells isolated 
from the limbus of discarded donor corneal tissue (due to its relative abundance), whereas 
keratoconic cells are extracted from central corneal buttons. When comparing healthy and 
keratoconic cells, the location the cells are harvested from should be kept the same. To this 
end, stromal cells were extracted from the limbus and central button of healthy corneas. This 
allows for comparison of keratoconic cells to both central and limbal healthy cells during 
development of a keratoconus model. Of concern is also the extraction method of stromal 
cells since the keratoconic cells donated and used in these experiments had been extracted via 
explant migration rather than the better-defined method using enzyme digestion of the tissue 
to release the cells. In this study, we explored the behaviour of stromal cells extracted via 
enzyme digestion and explant migration from central and limbal zones of the cornea in order 
to better understand the effects extraction method may have had on keratoconic cells. 
2. Introduction  
2.1. Stromal cell population within the stroma 
Intercalated within the lamellae of the stroma is a population of cells called keratocytes. 
Keratocytes in the stroma secrete and organize transparent matrix components essential for 
corneal tissue function (Jester et al., 1999). Dendritic processes allow these cells to form a 
cellular network within the tissue (Muller et al., 1995). The cells themselves possess unique 
properties among fibroblasts due to their cytoplasmic proteins, particularly crystallins such as 
ALDH1A, which allow the cell to match the refractive index of its surrounding ECM and 
minimize light scattering (Jester, 2008). The majority of keratocytes are located in the anterior 
portion of the cornea, near to the epithelium. This localization is ideal due to the majority of 
corneal stromal damage occurring in this anterior portion of the stroma (Moller-Pedersen et 
al., 2000). The position of the stromal cells is partially mediated by epithelial cells’ secreted 
factors that cause persistence in stromal cells closest to the epithelium (Torricelli et al., 2016). 
Among these secreted factors is the Transforming Growth Factor-β (TGF-β) family, with 
TGF-β1 and TGF-β2 causing differentiation of keratocytes and preventing their apoptosis 
while TGF-β3 prevents differentiation while also maintain survival (Karamichos et al., 2013). 
The survival of stromal also seems to be regulated by the epithelium but the stromal cells also 
provide support to the epithelial basement membrane by secreting proteins such as perlecan 
and nidogen-2 (Torricelli et al., 2015). Previous experiments showed that epithelial 
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debridement invariably lead to stromal cell apoptosis (Zieske et al., 2001). Keratocytes also 
tend to localize nearest to the sensory nerve fibres that populate the densely innervated the 
Bowman layer and its sub-basal plexus (Poole et al., 2003, Yang et al., 2018). The sub-basal 
plexus is itself part of the anterior stroma and there is therefore physical contact between the 
nerves and stromal cells. There exists a paracrine relationship between the two where stromal 
cells have been shown to support some regeneration in the damaged nerves, although this was 
in chickens (Yam et al., 2017). 
 
2.2. Activation and differentiation of stromal cells 
Stromal cells are normally found embedded within the stromal ECM in a dormant state, 
becoming activated when wound healing is required or as a response to any disruption to the 
stroma such as trauma or infection. When an injury occurs, keratocytes at the wound site or 
adjacent will undergo apoptosis, this response initiates an inflammatory response and can 
reduce the chances of viral infection (Wilson et al., 1996). Replacement of lost keratocytes 
requires activation of adjacent keratocytes during wounding; this active state is characterized 
by a change in morphology to fibroblasts: larger spindle-like cells, increased organelle 
content and loss of cytoplasmic granules (Fini and Stramer, 2005). This is in contrast to 
normal keratocyte morphology where cells are stellate or dendritic with a triangular body 
(Espana et al., 2003). These cells also break away from cell networks they may have formed 
while quiescent. The activation process is mediated by growth factors like TGFβ1, FGF and 
PDGF (Ljubimov and Saghizadeh, 2015). The newly activated cells then migrate to the 
wound area and begin the remodelling process by producing ECM-digesting enzymes. As the 
keratocytes lose their quiescent state, common markers of quiescence such as CD34, 
keratocan, ALDH3, lumican and decorin also begin disappearing (Espana et al., 2003, 
Fernandez-Perez and Ahearne, 2019). The activated fibroblasts express smooth-muscle actin 
and desmin, becoming contractile to effect wound closure (Chaurasia et al., 2009). Of note is 
that only one soluble growth factor has been documented as having quiescence-inducing 
functions on corneal stromal cells, TGFβ3 (Karamichos et al., 2011). Unpolymerized F-actin 
in the stromal cell cytoplasm congregates to form stress fibres within the cell (Petroll et al., 
2004). 
 
Activated keratocytes lose expression of proteins associated with cellular transparency such 
as aldehyde dehydrogenase 1A1 and crystallins (Jester et al., 1999). Activated keratocytes 
may also become myofibroblasts and express increased levels of alpha smooth muscle actin 
(αSMA). These contractile cells are typically found only at wound sites to aid in closure by 
 35 
enlarging and spreading. Myofibroblasts will also produce ECM crosslinkers and MMPs to 
remodel damaged stroma (Ebihara et al., 2007). While the myofibroblasts and fibroblasts play 
an essential role in wound healing of the cornea, these differentiated cell states are also 
associated with multiple pathological processes like corneal haze and scarring among others 
(Connon et al., 2003). Studies into the behaviour of stromal cells during surgical wound 
events found that stromal cells near the wound would differentiate into myofibroblasts, 
resulting in a fibrotic haze. The fibrous matrix would resolve itself into a more transparent 
matrix over the two following months and the differentiated cells would undergo apoptosis 
(Kivanany et al., 2018). In the case of chronic or particularly severe wounds, the 
differentiated cells may be unable to undergo apoptosis or revert to a quiescent state. These 
cells may then produce higher levels of inflammatory cytokines and matrix 
metalloproteinases, exacerbating corneal damage (Jester et al., 1999). Conserving the 
undifferentiated state of stromal keratocytes until fibroblastic differentiation is required as a 
vital role of signalling factors in the stroma. 
 
Keratocytes exhibit low self-renewal capability and need to be replaced by proliferating 
progenitor cells. In the corneal limbus, there is a posited to be a population of stromal cell 
progenitors that express markers associated with mesenchymal stem cell function such as 
ABCG2 and Pax6 (Du et al., 2005). These cells were also found to express genes associated 
with neural development such as NGFR and CDH2 (Funderburgh et al., 2016). The 
presentation of neural markers is in line with the neural crest origin of the limbal stromal stem 
cells (Pinnamaneni and Funderburgh, 2012). Importantly, this population of cells does not 
express classical hematopoietic or endothelial marker sets, ensuring that this is a distinct 
population of progenitor cells unique to the cornea. One more marker of note expressed by 
these limbal stem cells is CD34. Although commonly associated with hematopoietic stem 
cells due to its discovery in the blood stem cells, CD34 is a common marker for a multitude of 
progenitors (Sidney et al., 2014). The exact functions of CD34 are not well known due to its 
extensive post-transcriptional modification although one of the most well-known functions is 
the regulation of adhesion, particularly immune cells such as mast cells (Nielsen and 
McNagny, 2008). The expression of CD34 has been shown to decrease in wounded corneal 
cells and is lost when stromal cells are cultured in vitro, likely due to differentiation (Toti et 
al., 2002b). These limbal stromal stem cells were also able to differentiate into adipocytes and 
osteocytes in culture when exposed to the appropriate cues, indicating a degree of plasticity 
(Polisetty et al., 2008). Limbal stromal stem cells are of particular interest for in vitro cultures 
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due to their maintenance of an enhanced potential to become functional keratocytes 
(Funderburgh et al., 2016).  
 
When extracting cells from the cornea, the limbal ring is typically used (as this is left over 
from the fairly common keratoplasty procedures). If isolating cells from the whole, intact 
cornea, it is reasonably assumed that the more proliferative limbal stromal cells will make up 
the bulk of any extended in vitro culture. The existence of a progenitor population in the 
limbus suggests that the limbal ring and central portion of the cornea will yield different cell 
types. Since keratoconic cells are typically isolated from the central portion of the cornea after 
lamellar keratoplasty such as DALK (deep anterior lamellar keratoplasty), limbal cells may 
not provide an accurate healthy control (Chwa et al., 2008). Keratoconic cells are also 
typically compared to cells isolated from the limbus or whole cornea (Karamichos et al., 
2012). If there exists a difference in behaviour between limbal and central cells, identifying 
this difference is important for any future work. 
 
2.3. Stromal cell extraction methods 
Prior to being cultured in vitro, primary keratocytes are typically extracted via one of two 
methods: enzyme digestion or explant migration. Enzyme digestion uses collagenase 
treatment to break down the collagen component of the matrix and release the cells within. 
Explant migration involves cutting the cornea into small pieces, adhering the tissue pieces to a 
surface and letting cells migrate out onto this surface (typically tissue culture plastic, but 
could also be a specialized biomaterial such as amniotic membrane). Both methods have been 
used to extract cells when investigating keratocyte behaviour in culture, it has been found that 
the two methods can aid in the isolation of separate populations, albeit with FACS as a final 
step to isolate a homogenous population. There has not been any investigation to see if 
isolating via either enzyme digestion or explant migration leads to different populations of 
cells (Karamichos et al., 2014). It could be assumed that explant migration biases extracted 
populations towards more migratory cells while enzyme digestion simply collects all cells 
contained in the tissue.  
 
2.4. Aims 
To better understand the effects of extraction method and location, cells were extracted from 
the cornea centre and limbus via both enzyme digestion and explant migration. Isolated cell 
populations were then cultured in serum free conditions and their survival was quantified. 
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Furthermore, it is possible that some cells do not migrate out of the tissue explants. To 
investigate this potential non-migratory cell population, the explants were digested once the 
migration had run its course. 
3. Methods 
3.1. Isolating cells from central and limbal stroma with collagenase 
Stromal cells were isolated from donor tissue as previously described in chapter 3, section 
1.5. Cells were then passaged and cultured in serum-free medium [DMEM:F12 medium, 1 x 
ITS liquid medium supplement (Sigma-Aldrich),1 х 10μM ascorbic acid (Sigma- Aldrich), 
1% penicillin/streptomycin (Invitrogen)] for three days prior to assays. Each subsequent 
experiment was performed three independent times using keratocytes from passages three to 
five from specific donors. The populations extracted via this method are termed enzdL if 
isolated from the limbal region or enzdC if isolated from the centre. To collect RNA from 
fresh, non-cultured cells, the RNA extraction protocol was performed on cells immediately 
after enzyme digestion from either the centre or limbus.  
 
3.2. Isolating cells from central and limbal stroma via explant migration- 
Stromal cells were isolated from donor tissue as previously described in chapter 3, section 
1.6. Cells were then passaged and cultured in serum-free medium for three days prior to any 
assays. The populations extracted via the explant migration method are termed exmL if 
isolated from the limbal region or exmC if isolated from the centre.  
 
3.3. Extracting non-mobile cells from explants post-migration 
Tissue pieces were collected and then underwent enzyme digestion as previously detailed in 
chapter 3, section 1.6 to extract any cells still inside the explant. The “resident” cell 
population digested out of the explants, after the initial migration phase is termed exenzL if 
extracted from the limbus and exenzC if extracted from the centre.  
3.4. Survival in serum-free conditions  
The Alamar blue
 
assay was used to assess keratocyte proliferation and viability in serum-free 
medium over a period of 11 days. Cells were initially seeded at a density of 100000 cells per 
cm2 in a 24 well plate after 3 days of serum starving. The cells were cultured in serum-free 
medium and assayed with Alamar blue days 1, 4, 6, 8 and 11 of culture. The cells were 
incubated with resazurin reagent (Sigma-Aldrich; prepared in 1:10 dilution using fresh culture 
medium) for 90 minutes at 37°C, after which 100 μl of culture supernatants (in triplicate) 
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were sampled for fluorescence emission analysis at 590nm using Varioskan LUX multimode 
microplate reader (ThermoFischer, Franklin, MA). The cells were then replenished with fresh, 
serum-free medium. To evaluate the effects of retinoic acid on cell survival, RA was added to 
serum free medium at a concentration of 1μM after being initially diluted from a powder 
stock (Merck, USA) to a concentration of 10mM in ethanol. Cell number was calculated by 
interpolation using a standard curve for fluorescence values of 150, 100, 80, 60, 40, 20, 10, 5 














Figure 5: Schematic representation of the methods of stromal cell extraction 
used and the 8 separate populations of stromal cells assayed. A whole 
cornea scraped of its endothelium and epithelium is separated into a limbal 
ring and a central button of 0.8cm diameter. Each of the two pieces is 
separately minced and undergoes either enzyme digestion or explant 
migration. The enzyme digested tissue releases cells that can then either be 
cultured for future experiments (enzdL and enzdC) or immediately used in 
transcriptional analysis (Fresh enzdL and Fresh enzdC). Cells that migrated 
out of explants are collected (exmL and exmC) while the tissue is digested 




3.5. Quantitative PCR 
Following 11 days of culture, RNA was extracted from the cells using an RNeasy Mini Kit 
(QIAGEN, UK) according to manufacturer specifications. The RNA was then treated with 
DNase to eliminate genomic DNA. Quality assessment of the RNA was performed using a 
Nanodrop 2000 spectrophotometer (Thermo Scientific, UK) to ensure the A260/A280 ratio was 
within the range of 1.7 to 2.0 and the A260/A280 was above 2:1. The RNA was then reverse-
transcribed into cDNA with the RT2 First Strand kit (Qiagen, UK) according to manufacturer 
specifications in a TC-Plus thermal cycler (Techne, Staffordshire, UK). The resulting cDNA 
was then assessed using the Nanodrop to ensure purity and suitable concentration. The qPCR 
reaction was carried out using direct dye binding in the Eco Real-Time PCR System 
(Illumina, USA) and the appropriate primers (Table 1). The following cycles: 10 minute 
denaturation at 95°C, followed by 40x cycles of 10 seconds at 95°C, 30 seconds at 60°C and 
15 seconds at 72°C. All values correspond to average ± SD of 3 independent experiments 
with expression of each gene of interest normalized to housekeeping gene GAPDH. 
 
4. Results 
4.1. Serum-free survival of healthy and keratoconic stromal cells 
After cells were enzyme digested from either the centre or limbal region of the cornea, they 
were cultured in 10% serum medium and allowed to proliferate. Once a large enough number 
of cells had been reached, serum-free medium was substituted into serum starved cells. After 
3 days of serum starvation, cells were seeded at a concentration of 100000 cells per well onto 
tissue culture plastic and left to survive. A population decline was seen in both enzdC and 
enzdL populations (Fig. 6A), with a steeper initial decline for central cells.  
 
Cells that were explant migrated from either the centre of limbal region of the cornea, were 
also cultured in 10% serum medium and allowed to proliferate. Once a large number of cells 
had been reached, serum-free medium was substituted in to serum starve the cells. After 3 
days of serum starvation, cells were seeded onto tissue culture plastic and left to survive. 
While seeding density was also of 100000, the first 24 hours of culture saw a ~50% reduction 
in cell number (Fig. 6B). Overall, both populations exhibited similar behaviour and survival 
rates under these basic cell culture conditions.  
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Figure 6: Survival of healthy and keratoconic stromal cells as quantified by Alamar blue 
assay. Data was obtained from 3 experiments (n=3) per cell type, each with a different donor 
(** for p<0.005, *** for p<0.0005). 
 
The explants where left between 10 and 14 days on culture surfaces to allow cells to migrate 
out. Once cells had migrated out of the explants, the explants were collected and set aside for 
further processing. Any non-migratory cell that may have remained in the explant was then 
extracted by enzyme digestion. These cells were then cultured in 10% serum medium and 
allowed to proliferate. Once an appropriate number of cells had been reached, serum-free 
medium was substituted to serum starve the cells. After 3 days of serum starvation, cells were 
seeded onto tissue culture plastic and left to survive. These cells were termed explant enzyme 
digested limbal (exenzL) and central (exenzC). Both the limbal and central cells showed rates 
of population decline very similar to an enzyme digested limbal population (Fig. 6C). This 
suggests that the cells obtained through enzyme digestion will not migrate out of explants and 
need to be digested out. Interestingly, the corneal centre explants have cells within them that 
apparently survive longer and die slower if explant migration is performed first. Keratoconic 
fibroblasts (KF) were previously explant migrated from the centre of the cornea, they were 
cultured in 10% serum medium and allowed to proliferate. Once a large number of cells had 
been reached, serum-free medium was substituted in to serum starve the cells. After 3 days of 
0 5 1 0 1 5
0
5 0 0 0 0
1 0 0 0 0 0
1 5 0 0 0 0










e n z d L
e n z d C
*
0 5 1 0 1 5
0
5 0 0 0 0
1 0 0 0 0 0
1 5 0 0 0 0













0 5 1 0 1 5
0
5 0 0 0 0
1 0 0 0 0 0
1 5 0 0 0 0











e xe n zC
0 5 1 0 1 5
0
5 0 0 0 0
1 0 0 0 0 0
1 5 0 0 0 0










e n z d L
exm C
K F






serum starvation, cells seeded onto tissue culture plastic and left to survive. The rate at which 
cell population declined amongst KF was most similar to enzdL (Fig. 6D), a surprising 
similarity as KF are central and explant migrated while enzdL are limbal and enzyme 
digested. 
4.2. Gene expression of healthy and keratoconic stromal cells 
Multiple important keratocyte markers were analysed at the gene transcript level and the most 
common method of stromal cell extraction, enzyme digestion of the limbus or enzdL, was 
used as a reference. Results showed that the method of extraction and the location of 
extraction both had a significant effect on the expression of several key genes. When 
digesting cells out of the centre of the cornea rather than the limbus, significantly higher 
transcription levels of DCN (368±122 fold increase), LUM (27±1 fold increase), RARA 
(5±0.7 fold increase), TIMP1 (3±0.01 fold increase) and ALDH3A1 (Fig. 7A, C, J, M and N). 
 
Extracting limbal stromal cells through explant migration also had an effect on gene 
expression profile of the stromal cell population. Explant migrated limbal cells had increased 
expression of CD34, LUM (246±45-fold increase), TIMP1 (12±0.3-fold increase) and COL1 
(5±0.3-fold increase) (Fig. 7C, E, J and K). Central cells showed rather different transcription 
profiles when migrated out, with increased expression of ALDH3 and KERA (5.7±1-fold 
increase). The population of cells that remains in the explant after migration did show some 
difference in expression, with increased LUM (83±7-fold increase), CD34 and COL1 (4±0.02 
fold increase) in the case of limbal cells while central cells showed increased ALDH3 and 
LUM (9±0.6 fold increase) with decreased CD34 and COL5 (7±0.04 fold decrease) (Fig. 7C, 
E, F, K and N).  
 
Finally, as all 6 of the previously described cells had been cultured prior to experiments, there 
was still the question of what gene expression was like in vivo or at least in freshly extracted 
cells. The fresh cells showed the most drastically different profile from the enzdL reference. 
CD34, a commonly accepted marker of plasticity and stem cell behaviour was much more 
transcribed in both fresh central (19±4-fold increase) and limbal (7±0.8-fold increase) cells 
(Fig. 7K). There was massively increased expression of ALDH3 in the limbal cells 
(366000±120000-fold increase) and smaller but still statistically significant increase in the 
central cells (Fig. 7N). KERA had significantly increased expression in fresh cells relative to 
the cultured cells (17000±3600-fold increase) (Fig. 7B). The fresh cells also expressed a 
larger amount of RARA (19±1-fold increase) (Fig. 7N). A number of genes also seemed 
inactive in the fresh cells compared to the enzdL reference. COL1 (11±0.5-fold decrease, 100-
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fold decrease), COL5 (5±0.2-fold decrease, 2.5±0.4-fold decrease) and αSMA (50±5-fold 





Figure 7: Fold change in gene expression for healthy stromal cells cultured in serum-free 
medium for 11 days. Gene expression was normalized relative to control group of enzyme 
digested limbal cells (solid blue fill). Extraction methods were: enzyme digestion (solid fill), 
explant migration (chequered fill), digestion of explant post-migration (diagonal stripe fill) 
and analysis immediately after digestion (pinstripe fill). Limbal cells (blue) and central cells 
(red) were both assayed. Data (mean ±SD) were obtained from three independent experiments 
(n = 3) and compared to enzdL using t-test (* for p < 0.05, ** for p<0.005, *** for p<0.0005, 
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Analysis of the same previously identified keratocyte markers in keratoconic cells showed 
that, similar to the survival rates of keratoconic stromal cells and healthy enzyme-digested 
limbal cells, the gene expression profile of the two cell types was also largely similar. 
However, differences were seen in the increased expression of MMP3 (10±0.6-fold increase) 
and LUM (26±0.3-fold increase) in keratoconic cells (Fig. 8). Vimentin expression was 
highest in the cultured central cells, enzdC and exmC, but was lower in the cultured limbal 




The extraction of corneal stromal cells is a relatively simple procedure, but when using 
healthy cells as controls in the construction of a 3D model of the stroma, a better 
understanding of how extraction and culture affects the cells is needed. To this end, three 
separate stromal cell extraction methods were identified and used to yield a total of 8 different 
populations of healthy cells. These healthy cells were assayed for survival in a serum-free 
environment, as would be found in the cornea. These healthy cells were also assayed for the 
transcription of stromal cell specific genes that relate to various functions and states of 
differentiation. Finally, keratoconic cells were compared to the healthy stromal cells to find 
out what differences exist between the diseased cells and the healthy cells. Findings at this 
stage informed what controls were to be used when designing the keratoconus model system. 
 
The cells extracted from the centre of the cornea appeared to perish faster in culture than cells 
extracted from the limbal area of the cornea. This is likely due to the presence of a progenitor 
population of cells with a greater proliferative capacity in the limbus. Although it should be 
noted that both the central and limbal cells eventually reach similar population numbers, the 
difference lies in the amount of time it takes to reach that point. The largest amount of 
variance was seen in the enzyme-digested limbal cells. This was due to some donors yielding 
cells that survived for a significant amount of time in culture, even proliferating slightly in 
serum free conditions, even though the cells were serum starved prior to experiments. The 
cells populations extracted by digesting the pieces of cornea that had been used for explant 
migration showed longer survival than the explant migrated cells. This suggests that in the 
case of both the central and limbal cornea, the more proliferative or better surviving cells are 
not migratory enough to leave the explants. While the limbal population of enzdL and exenzL 
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appeared similar in respect to their survival, a great difference is seen in the rate at which 
central population perish. The cells digested from pieces used in explant migration performed 
much better than cells extracted directly from the intact corneal button. It is possible that 
allowing cells to first migrate out of the corneal centre and then culturing the small number of 
cells left behind obtains a more homogenous population of progenitors. This seems contrary 
to the current prevailing hypothesis of progenitor cells existing only in the limbus. Further 
investigation into marker profiles and differentiation potential could reveal if the corneal 
centre does indeed house a small number of progenitor cells that could be isolated. 
 
Extraction method also had an effect on cell survival, explant migrated cells saw faster 
population reduction in the first few days, faster even that enzyme-digested central cells. 
These cells showed very little variance among donors and lost the majority of their population 
in the first day of culture in serum free medium. It is possible that this large loss of cells is 
due to an inability to adhere. The serum starvation prior to the seeding of the cells occurred 
after the cells had formed adhesions. Once the cells were starved for three days, they were 
then transferred to culture plates. As serum free medium doesn’t contain the adhesion 
promoters found in serum medium, it is possible that cells isolated via explant migration 
cannot build adhesion complexes in serum-free conditions and therefore largely perish when 
transferred. While this serum-starving step was present in all methodologies and was 
performed on all cell types assayed, explant migrated cells may be the most responsive due to 
their migratory and adhesion-based isolation.  
 
Currently, the only method of obtaining a large number of primary corneal stromal cells from 
human tissue is to expand these cells in serum-containing medium. While this method is 
simple and robust, the phenotype of the cells is altered drastically due to the new 
environmental cues and rapid cell cycling (Beales et al., 1999). This is most obvious when 
observing the fold-changes in αSMA and CD34, a marker of differentiation and a marker of 
plasticity respectively. The increase in αSMA expression from enzdL and enzdC cells 
compared to the uncultured Fresh enzdL and Fresh enzdC suggests differentiation towards the 
more contractile myofibroblast lineage (Chen et al., 2007). A decrease in CD34 expression is 
also observed after culture in serum medium, with Fresh enzdL and Fresh enzdC cells 
showing the highest amounts of CD34 mRNA while cultured counterparts showed far lower 
amounts. In particular, central cells seem to suffer the greatest loss in CD34 transcription 
following in vitro culture. The loss of CD34 could be interpreted either as a differentiation of 
progenitor cells towards a lineage that lacks the expression of CD34 or as a loss of CD34-
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expressing cells due to competition with stromal cells better suited to serum-containing 
medium. Keratocan, MMP2 and ALDH3 gene expression follow a trend similar to CD34 with 
higher expression before serum culture while TIMP1 and Collagen type V and Collagen type 
I follow the pattern of αSMA with lower expression prior to serum culture.  
 
When tissue is retrieved from a donor of keratoconic tissue at the time of keratoplasty, only 
parts of the central button are harvested. This is because the limbus must remain intact to 
prevent harmful vascularization of the cornea (Dua and Azuara-Blanco, 2000). This means 
that keratoconic stromal cells (KF) currently being investigated are all central stromal cells. 
This is particularly relevant when comparing KF to healthy controls as healthy limbal cells 
may be different purely due to differences in the location of the tissue of origin rather than 
due to keratoconus. To better compare KF to healthy cells, central stromal cells were isolated. 
Following serum and subsequent serum-free culture, these central cells showed clear 
differences from limbal cells, with greater expression of decorin, lumican, retinoic acid 
receptor A and TIMP1. This pattern of expression with large proteoglycan RNA production 
suggests cell behaviour geared towards matrix organization (Chen et al., 2015). Keratoconic 
cells lacked the higher expression of decorin and RARA but did have increased MMP3. This 
could be due to a more degradative activity of keratoconic cells in culture. 
 
Keratoconic cells were extracted using explant migration, a method of primary cell isolation 
that relies on cell movement. Dr. Karamichos performed the extraction of keratoconic cells by 
culturing the tissue in serum medium to entice the cells out of the tissue and onto plastic 
(Karamichos et al., 2012). When isolating healthy stromal cells in the same manner, it is not 
possible to collect a sample of explant migrated cells that were not exposed to serum medium. 
In order to better understand the effects of explant migration on gene expression, healthy 
stromal cells were extracted from the limbus of donor corneas via enzyme digestion and 
explant migration. The resulting two populations were cultured in serum to a large number 
and then cultured in serum-free conditions. Results showed that exmL retain specific 
differences with enzdL even after both were subjected to serum culture. Increased expression 
of lumican, MMP1, MMP3, TIMP1 and Collagen Type I in the exmL population suggest 
increased matrix-remodelling activity. This is in line with a migratory profile that would 
require deconstruction and reconstruction of ECM. In central stromal cells, the enzyme 
digested enzdC and explant migrated exmC also showed some differences although not in the 
same genes as limbal cells. Lower expression of decorin, lumican, MMP1, MMP3 and TIMP1 
were observed in exmC relative to enzdC.  
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Following a better understanding of the effect of extraction method on stromal cells, the 
question became: Is the behaviour of keratoconic cells a product of extraction method, 
extraction location, serum culture or any combination of the three? To best answer this, 
keratoconic cells were compared to healthy stromal cells extracted from the same location 
with the same extraction method: explant-migrated central stromal cells. When it came to 
survival, keratoconic cells outperformed exmC by surviving seeding in greater numbers and 
lasting for longer. The keratoconic cells seemed most similar to enzdL in respect to survival 
and some gene expression. When comparing expression profile, KF showed a profile that 
could not be entirely explained simply by extraction method or location. KF expressed more 
lumican, MMP1 and MMP3 than exmC while also showing some similar expression patterns 
to cultured limbal cells like lower ALDH3 and vimentin. It is likely that serum culture and 
subsequent serum-free culture had an effect on KF, particularly keratocan and CD34 
expression, though it cannot be known for sure until freshly extracted cells can be analysed. 
Overall, KF cells show a distinct set of serum-free survival and expression behaviours that 
cannot be explained purely by culture, extraction method and location. The difference 
observed between KF and healthy cells must be due to the disease itself rather than 
manipulation of the cells. 
  
 50 
Chapter 5: Culturing Stromal Cells in Serum-Free Conditions 
1. Abstract 
Stromal cell behaviour is regulated by the cell’s environment. The cornea and the cells within 
provide a multitude of cues such as nutrient concentrations, oxygen content, matrix physical 
properties, cytokines and hormones. A wound or disease will change the environmental cues 
and lead to a change in cell behaviour. When extracting stromal cells and subsequently 
culturing these cells in serum medium, these in vivo cues are lost. Tissue culture plastic lacks 
the mechanical properties of corneal ECM, specific growth factors are replaced by the broad 
spectrum that serum provides, oxygen concentration is now unregulated and neighbouring 
secretory cells are no longer around. If a model is to be built with stromal cells, keratoconic or 
otherwise, the behaviour of the cells must be returned (as close as practicably possible) to that 
which it exhibited in vivo. This can partially be achieved through the removal of serum and 
addition of retinoic acid, a metabolite of vitamin A and potent regulator of corneal function. 
2. Introduction  
2.1. Reproducing the stromal cell native environment 
Stromal cells like all cells are dependent on signals provided largely by the ECM and 
surrounding cells (Wu et al., 2012). These signals determine the way the cells respond during 
migration, adhesion, proliferation and differentiation. Epithelial cells have been documented 
as the principal cellular coordinator of stromal cell fate through their two-way communication 
across the Bowman layer (Wilson et al., 2003). Loss of epithelial cells will exacerbate wound-
healing reactions in the stromal cells and lead to increased differentiation (Nakamura et al., 
2002). This stromal cell differentiation can be reproduced in vitro by simply adding serum to 
stromal cell cultures (Jester and Ho-Chang, 2003). While it would be desirable to use corneal 
epithelial cells from keratoconic sources to build a model, these cells pose unique challenges 
in their acquisition, culture and storage. To compensate for the lack of epithelial cells in the 
model, serum-free conditions will be used and although the absence of serum drives rapid 
population decline in stromal cells as seen in Chapter 4, different medium supplementation 
may be used to overcome cell loss in vitro. 
 
2.2. Modelling the corneal stroma 
When studying a tissue and the diseases that affect it, a model is typically used. The cornea 
has multiple existing animal models, each with their own advantages and disadvantages. For 
example, while rabbits are commonly used as corneal models, the microanatomy of the 
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cornea has clear differences, particularly in innervation (Ojeda et al., 2001). Mouse corneas 
also differ from humans by becoming significantly thinner towards the periphery (Henriksson 
et al., 2009). When attempting to model keratoconus in animals, the problem becomes 
compounded. Since the exact cause of keratoconus is unknown, it is difficult to replicate the 
disease in an animal. Although keratoconus or at least a very similar disease has been 
observed in monkeys (Kodama et al., 2010), there doesn’t exist a genetic lineage of animals 
with keratoconus. To produce animal models of keratoconus, effort has been made to 
replicate the symptoms of the disease, usually through mutations that causes a keratoconus-
like keratopathy (Tachibana et al., 2002). While animal models provide several biological 
challenges, there are also cost and ethical implications when using animals to study tissue or a 
disease. Multiple cell culture‐based corneal models have been explored with the intended 
purpose of overcoming the challenges associated with animal experiments and to replace 
animal models with viable in vitro systems. 
 
In vitro models of corneal tissue offer unique advantages for the study of cell behaviour such 
as simplification of the more complex in vivo environment, lower cost than human or animal 
models and relatively easy high throughput analysis. In vitro models of the cornea have 
previously been constructed using epithelial cells (Gonzalez-Andrades et al., 2016), stromal 
cells (Reichl et al., 2004) and, in rare case, endothelial cells (Orwin and Hubel, 2000) or 
neuronal cells (Suuronen et al., 2004). These cells are typically encased in a substrate that will 
replicate some of the properties of the highly specialized corneal collagen matrix such as 
biodegradability, geometry or stiffness. The final component is the medium used to feed the 
cells; in a model, the formulation should aim to replicate as many of the in vivo cues as 
possible or at least induce cellular behaviour similar to what is observed in the cornea. 
 
2.3. Medium supplementation 
When cultured in vitro, the chemical cues and nutrients that allow keratocytes to thrive have 
to be reproduced. The basal medium formulation used for mammalian cell culture was first 
set by Harry Eagle, described as being isotonic, pH-neutral and containing molecules 
necessary for cell survival such as vitamins, amino acids, salts and sugars (Eagle, 1955). A 
later modified recipe of Eagle medium called modified Eagle medium (Greenbaum et al.), 
included greater amounts of amino acids and vitamins, increasing nutritional value (Eagle, 
1959). One of the later iterations of Eagle medium, modified by Renato Dulbecco, included a 
fourfold increase in vitamins, amino acids and glucose combined with the new inclusion of 
iron and pH indicator phenol red (Dulbecco and Freeman, 1959). The sequence of tweaks to 
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the original basal medium formulation eventually led to the combination of two existing 
medium recipes (Barnes and Sato, 1980). DMEM and Ham’s nutrient mixture F-12 where 
mixed to combine the high nutritional contents of DMEM with the components of F-12 like 
bitotin, putrescin, glycine and proline that aren’t found in DMEM (Ham and McKeehan, 
1979). The medium, known as DMEM/F-12 is typically supplemented with a stabilized form 
of L-glutamine to prevent ammonia build-up and ensure cell survival during long-term culture 
(Atanassov et al., 1998). This DMEM/F-12 is the most widely used cell culture medium for 
keratocytes and can be supplemented with serum. For keratocytes, the presence of serum in 
DMEM/F-12 has been shown to drive cell proliferation (Priyadarsini et al., 2015). 
 
Historically, serum has been an important part of mammalian cell culture methods. Serum 
provides growth enhancers and protective elements to cells, allowing cultures to thrive. 
Adhesion promoters, hormones, protease inhibitors, low molecular weight nutrients, and 
growth factors are all present in serum (Francis, 2010). When cultured in the presence of 
serum, keratocyte undergo behavioural changes, shifting from a quiescent dendritic state into 
fibroblastic proliferating cells. This change resembles the normal wound healing response 
seen in vivo (Beales et al., 1999, Jester et al., 1999). While serum provides many benefits, 
there exist multiple reasons why serum-free cultures are desirable. Firstly, the collection of 
serum is costly and considered inhumane by some (van der Valk et al., 2004). The variance 
between batches of serum due to seasonal, continental and animal variance affects the 
reproducibility of experimental results, a crucial requirement for many cell cultures that 
require defined and non-variable supplement. Furthermore, sera or any reagent of animal 
origin caries the risk of contamination; viral contamination has been noted in up to 50% of 
commercial foetal bovine serum (Wessman and Levings, 1999, Levings and Wessman, 1991). 
A serum-free culture system is therefore desirable to avoid the complications that accompany 
serum use, although the benefits of serum need to be reproduced to support proliferation and a 
degree of quiescence. 
 
Instead of serum, the basal medium DMEM/F12 has to be supplemented with different 
additives. The ITS supplement groups three such additives, namely insulin, transferrin and 
selenium. The ITS mix first showed promise in enhancing germ cell maturation and 
embryogenesis when coupled to ascorbic acid (Cordova et al., 2010). It has been shown that 
medium supplemented with ITS allows for adequate culture of keratocytes (Gouveia and 
Connon, 2013). The insulin can maintain the keratocyte phenotype during proliferation, 
delaying appearance of fibroblastic markers (Musselmann et al., 2005). Transferrin is an iron 
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transfer protein necessary for cell survival in culture. Selenium is a trace element used in anti-
oxidative pathways that protect cells (Helmy et al., 2000). What makes ITS particularly 
attractive as a supplement for keratoconic cells is that each component addresses a 
pathological facet of the disease. Fibroblastic and myofibroblastic differentiation are both 
reported in keratocytes extracted from keratoconic patients, insulin reportedly inhibits these 
phenotypes in culture. Transferrin polymorphisms occur in some cases of keratoconus, 
supplementing cells with transferrin may offset these polymorphisms (Wojcik et al., 2013). 
An increase in oxidative stress and a decrease in anti-oxidative pathways are both hallmarks 
of keratoconus; an antioxidant like selenium may combat this aspect (Arnal et al., 2011).  All 
vitamins necessary for keratocyte survival are present in DMEM/F12, although increasing the 
amounts of specific vitamins can have positive effects. Ascorbic acid, also known as vitamin 
C, can be supplemented to basal medium to increase collagen synthesis. The addition of 
ascorbic acid to a variety of cell types showed effects on differentiation and proliferation 
(Huijskens et al., 2015, Takahashi et al., 2003). Ascorbic acid doesn’t seem to affect growth 
or directly cause differentiation, instead activating ECM production pathways that lead to new 
cell behaviour (Builles et al., 2006). 
 
Of final note regarding the composition of medium for stromal cell culture is glucose 
concentration. The cornea itself is an avascular organ with lower availability of metabolites 
compared to other tissues. Glucose is a nutrient that the cornea receives very little of. The 
human cornea has a glucose concentration of around 1g/L while the DMEM/F12 used here 
and in multiple other stromal cell experiments has a glucose concentration of 4.5g/L.  The 
effects of low glucose were previously investigated to better understand the effect this had on 
cells (Foster et al., 2015). Compared to high-glucose medium in serum-free conditions, low-
glucose medium was found to enhance survival and induce cellular characteristics that closely 
resemble the keratocyte in vivo. Glucose concentration seems to be the most obvious next step 
in formulating a medium that best replicates the stromal environment in order model the 
cornea. 
 
2.4. Retinoic Acid 
Another vitamin with positive effects on keratocytes is retinoic acid (RA), a metabolite of 
vitamin A also known as “activated vitamin A”. To maintain integrity and proper 
functionality, the cornea requires RA to regulate transcription of specific genes (Nezzar et al., 
2007). Past experiments involving the culture of keratinocytes in the presence of RA have 
shown that RA can either inhibit and induce proliferation (Marcelo and Madison, 1984). RA 
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may also drive the expression of differentiation markers in keratocytes, such as keratin (Fuchs 
and Green, 1981) and filaggrin (Fleckman et al., 1985). This effect on differentiation is not 
limited to keratinocytes, in culture; RA can stimulate the differentiation of many pluripotent 
stem cell types. This previous data suggest that RA could be modulating the activation of 
stem cells to transient proliferating cells. Overall, the effect of RA on proliferation and 
differentiation seems concentration dependent. Cultures of keratocytes did show that RA 
would enhance proliferation and stratification while reducing mobility in serum-free 
conditions (Gouveia and Connon, 2013). 
 
2.5. Aims 
To construct a model of keratoconus in vitro, stromal cells need to be cultured in serum-free 
conditions without perishing. To this end, RA was used to keep cells alive as it is a significant 
molecular cue of the cornea during development and maintenance of the tissue.  
 
3. Methods 
3.1. Preparation of RA  
3 mg RA powder (Merck, USA) was solubilized in 10mL of absolute ethanol to produce a 
1mM stock solution, which was sterile-filtered and stored in aliquots at −80°C for up to 1 
month. RA was added to medium immediately before use by diluting in serum-free 
DMEM/F12 at a ratio of 1:1000 medium volume for a final concentration of 1μM. 
3.2. Cell survival in RA-supplemented medium 
The Alamar blue
 
assay was used to assess keratocyte proliferation and viability in RA-
supplemented serum-free medium over a period of 11 days. Cells were initially seeded at a 
density of 100000 cells per cm2 in a 24 well plate after 3 days of serum starving. The cells 
were cultured in serum-free medium supplemented with RA. The cells were assayed with 
Alamar blue at days 1, 4, 6, 8 and 11 of culture. The cells were incubated with resazurin 
reagent (Sigma-Aldrich; prepared in 1:10 dilution using fresh serum-free culture medium with 
no RA) for 90 minutes at 37°C, after which 100 μl of culture supernatants (in triplicate) were 
sampled for fluorescence emission analysis at 590nm using Varioskan LUX multimode 
microplate reader (ThermoFischer, Franklin, MA). The cells were then washed once with 
PBS to remove excess reagent and then replenished with fresh, serum-free medium. Cell 
number was calculated by interpolation using a standard curve for fluorescence values of 150, 
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100, 80, 60, 40, 20, 10, 5 x 104 cells. All values correspond to average ± SD of 3 independent 
experiments. 
3.3. Stromal cell gene expression in RA-supplemented medium 
Following 11 days of culture, RNA was extracted from the cells RNeasy Mini Kit (QIAGEN, 
UK) according to manufacturer specifications. The RNA was then treated with DNase to 
eliminate genomic DNA. Quality assessment of the RNA was performed using a Nanodrop 
2000 spectrophotometer (Thermo Scientific, UK) to ensure the A260/A280 ratio was within the 
range of 1.7 to 2.0 and the A260/A280 was above 2:1. The RNA was then reverse-transcribed 
into cDNA with the RT2 First Strand kit (Qiagen, UK) according to manufacturer 
specifications in a TC-Plus thermal cycler (Techne, Staffordshire, UK). The resulting cDNA 
was then assessed using the Nanodrop to ensure purity and suitable concentration. The qPCR 
reaction was carried out using direct dye binding in the Eco Real-Time PCR System 
(Illumina, USA) and the appropriate primers (Table 1). The following cycles: 10 minute 
denaturation at 95°C, followed by 40x cycles of 10 seconds at 95°C, 30 seconds at 60°C and 
15 seconds at 72°C. All values correspond to average ± SD of 3 independent experiments 
with expression of each gene of interest normalized to housekeeping gene GAPDH. 
 
4. Results 
4.1. Survival of healthy and keratoconic stromal cells with RA 
 When exposed to RA at a concentration of 1uM, limbal cells were able to proliferate (Fig. 
9A). While the population of central cells did not increase, it didn’t decrease either (Fig. 9B). 
Whether this was as a result of cells not dying or due to rates of proliferation and cell death 
cancelling each other out remains to be better understood. The addition of RA to serum free 
medium when culturing explant migrated cells had similar effects to those seen when 
culturing enzyme digested cells. The limbal cells showed a population increase when exposed 
to RA (Fig. 9C). The explant migrated central cells showed a high percentage increase in 
population, much higher than any other population (Fig. 9D). It should be noted however that 
these central cells have the poorest initial adherence (as low as 20%) and that therefore, any 
population increase is in fact quite small. This is a relevant finding however as it suggests that 
the enzyme digested central cells may proliferate rather than keep the cells already there alive. 
Keratoconic cells were also cultured in serum free medium supplemented with 1μM of RA. 
Keratoconic stromal cells proliferated when cultured with RA (Fig. 10), suggesting that a 
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Figure 9: Survival of explant migrated and enzyme digested healthy stromal cells in retinoic acid 
serum- free medium as quantified by Alamar blue assay. Data was obtained from 3 experiments 
(n=3) per cell type, each with a different donor. (* for p < 0.05, ** for p<0.005, *** for 
p<0.0005, **** for p<0.0001). 
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Figure 10: Survival of keratoconic stromal cells in RA serum- free medium as quantified by 
Alamar blue assay. Data was obtained from 3 experiments (n=3) per cell type, each with a 
different donor (* for p < 0.05, ** for p<0.005, *** for p<0.0005, **** for p<0.0001). 
 
4.2. Gene expression of healthy and keratoconic stromal cells with RA 
Multiple important keratocyte markers were assayed at the transcript level to determine 
whether RA had an effect on healthy stromal cells and keratoconic cells. Results showed that 
RA did have an effect on the expression profile of both healthy and keratoconic, with similar 
shifts in behaviour for both cell types. Expression of ALDH3 did change across all cell types 
with the addition of RA, significant difference was only detected in limbal and keratoconic 
cells (Fig 11N). KERA also showed higher expression in the presence of RA, with a 
statistically significant difference observed in all cell types except exmC (Fig. 11B). Decorin 
expression trended downwards when exposed to RA, with central cells like exmC, enzdL and 
KF seeming the most affected although with no statistical significance (Fig. 11A). MMP3 
expression was only affected in enzyme digested cells, with the most change being seen in the 
limbal population (Fig. 11I). LUM expression is the first gene with both significant increases 
and decreases accompanying RA addition. The lower lumican expression initially seen in 
enzdL was increased while the higher expression in exmL was decreased (Fig. 11C). RA 
brought lumican expression in all cell types to a similar level, suggesting a bidirectional 
regulatory effect from RA. TIMP1 expression was significantly affected in enzdL, exmC, and 
KF (Fig. 11J). MMP1 expression was affected in both of the explant migrated cells types, 
decreasing in the limbal cells and increasing in the central cells (Fig. 11G). Genes involved in 
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matrix degradation seemed more reactive in explant migrated cell types although not in KF. 
This somewhat reinforces the identity of keratoconic cells having some unique behaviours 
despite being extracted through migration. Vimentin expression was driven down 
considerably, though not in a statistically significant manner, across all cell types with the 
most drastic change being observed in the central populations. The expression of αSMA was 
increased in the enzyme digested populations and was reduced in the explant migrated cells, 
with statistical significance observed in both cases. KF seemed to not react to RA in regard to 
its αSMA expression. RA receptor, RARA, (Greenbaum et al., 2017) expression in enzdL 
observed an increase in the presence of RA, no change could be seen in other cell types. 
Expression of Collagen I was reduced in enzdL and exmL while increasing in enzdC. 
Collagen V on the other hand seemed reduced across all cell types but only significantly for 
enzdL (Fig. 11 E and F). MMP2 expression seemed to have been most affected in the exmC 
populations, which is in line with previous changes in behaviour specific to explant migrated 
cells affecting matrix digestion-related genes (Fig. 11H). However, none of the MMP2 
expression changes were deemed statistically significant. Finally, CD34 expression was 
reduced in all cell types following RA exposure with the exception of exmC (Fig. 11K). 
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Figure 11 : Fold change in gene expression for healthy stromal cells and keratoconic 
fibroblasts cultured in serum-free medium without RA (left portion of graph) or with RA 
(right portion of graph) for 11 days. Gene expression was normalized relative to control group 
of enzyme-digested limbal cells in serum-free medium without RA (solid blue fill). Extraction 
methods were: enzyme digestion (solid fill) and explant migration (chequered fill) for healthy 
cells. Healthy limbal cells (blue), healthy central cells (red) and keratoconic cells (green)were 
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used one-way ANOVA to compare RA-supplemented culture to respective non-supplemented 
control (* for p < 0.05, ** for p<0.005, *** for p<0.0005, **** for p<0.0001). 
 
5. Discussion 
RA has already been studied for its role in guiding mesenchymal and corneal morphogenesis, 
as well as proliferation and differentiation of stromal cells (Gouveia and Connon, 2013; 
Abidin et al., 2015). At a concentration of 1µM, RA was found to cause proliferation and 
block migration in corneal stromal cells cultured in serum free environment. This made RA 
an interesting candidate for the maintenance of a stromal cell population in vitro without 
serum. At a concentration of 1μM, RA triggered proliferation in all cell populations assayed, 
with the exception of enzyme-digested central cells. While explant migrated central cells did 
show a large percentage increase in population, although their starting population was much 
smaller than other cell types assayed and any small increase in cell number would appear as a 
larger percentage increase. This was due to explant migrated central cells reacting very poorly 
to detachment and typically not reattaching if seeded into a serum free environment; the lower 
number of attached cells meant that a smaller amount of RNA was collected, a sufficient 
amount for analysis was still extracted.  As for keratoconic cells, once again we see a 
behaviour very similar to limbal cells rather than central cells, with cell numbers increasing 
rather than stagnating. RA was therefore selected as one of the key supplements that will keep 
keratoconic cells alive in the model. 
 
The addition of retinoic also had a significant impact on the expression of multiple genes 
essential to stromal cell function. Large increases where observed in the expression of 
ALDH3A1, a gene that codes for an aldehyde dehydrogenase responsible for the protection of 
corneal transparency. This protein composes a large portion of the corneal soluble protein 
content and its high expression when exposed to RA is encouraging as this suggests that in 
vivo behaviour may be occurring. Of interest is that, while the increases in ALDH3A1 were 
not deemed statistically significant, limbal cells exposed to RA reached higher concentrations 
of ALDH3A1 mRNA compared to their central counterparts. This suggests perhaps a greater 
sensitivity to RA in limbal cells, which keratoconic cells also share, further supporting the 
idea that keratoconic cells are limbal-like while residing in the corneal centre.   
 
Another gene that showed notable increase is KERA, encoding for keratocan, a proteoglycan 
essential for corneal transparency. All stromal cells assayed, healthy and keratoconic, showed 
increased KERA expression when exposed to RA. Decorin, another important proteoglycan, 
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had its gene expression reduced by RA. Lastly, the proteoglycan lumican showed a varied 
response to RA based on the cell type. Taken together, these three leucine-rich proteoglycans 
indicate a shift in the organization of matrix produced by the cells. Previous research showed 
that keratan sulphate proteoglycans, like keratocan and lumican, are involved in the regulation 
of collagen fibril diameter while dermatan sulphate proteoglycan, like decorin, control 
interfibrillar spacing and lamellar adhesive properties of corneal collagens (Michelacci, 
2003). The reduction in decorin expression and increase in keratocan expression could be 
interpreted as a cellular effort to regulate fibrillar diameter and foregoing some control of 
fibrillar spacing. The exact implication this would have in a 2D culture system’s ECM over 
such a short timespan remains unclear. 
 
Another facet of ECM maintenance affected by RA is the expression of matrix 
metalloproteinase-coding genes. MMP1, 2, and 3 were all affected to some degree. Explant 
migrated cells were the most significantly affected with an increase in MMP3 for both limbal 
and central explant migrated cells. MMP1 showed and increase for exmC but a decrease for 
exmL. Finally, while MMP2 was not found to increase or decrease significantly after addition 
of RA, the larger variations in MMP2 expression in healthy central cells disappeared after RA 
supplementation. Taken together this data seems to suggest that explant migrated cells 
became more involved in matrix degradation in the presence of RA. However, the expression 
of general MMP-inhibitor TIMP1 also changed with RA, particularly in exmC. It could be 
interpreted that while degradative pathways are more active in exmC, they are more heavily 
regulated or inhibited. The different reaction of limbal and central explant migrated cells to 
RA in regards to MMP1 may ultimately have the same result due to increased TIMP1 
expression compensating for upregulated MMP1 in exmC. Of relevance is also that while KF 
where isolated using the exact same techniques and tissue location as exmC, the reactions to 
RA in respect to MMP gene expression are very different. A lack of sensitivity to 
environmental cues in guiding gene expression may be a novel facet of keratoconus at a 
cellular and it has previously been observed that TIMP1 shows reduced expression in 
keratoconic corneas (Riley et al., 1995).  
 
The most important aspect of ECM-regulation is the production of collagen by the stromal 
cells. The addition of RA also affects the expression of genes coding for these essential ECM 
building materials. Collagen type I saw little change in all cell types with the exception of 
exmL, where a significant decrease in expression was observed after culture with RA. 
Collagen type V was reduced significantly in all cell types assayed. As collagen type I is the 
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predominant type in the corneal stroma (Ihanamaki et al., 2004), RA may be limiting the 
production of non-essential collagens rather than increasing production of type I. The 
reduction of collagen type V is still concerning as this collagen has a role in regulating the 
ultimate diameter of collagen fibrils (Birk, 2001), an important role in a tissue where fibril 
geometry dictates light scattering. It is possible that this reaction was a product of culture on 
plastic for a short period of time and that longer culture periods would have seen the stromal 
cells shift to a behaviour more focused on matrix re-organization with more type V being 
produced. Further work using collagen gel culture and longer culture periods was of interest 
in pursuing this investigation. 
 
Inside the cells, the cytoskeleton and the forces that act upon it also seemed to be affected by 
the addition of RA. Vimentin, a cytoskeletal protein responsible for cell structure and 
movement (Mendez et al., 2010), was found to have reduced expression in all stromal cells, 
healthy and keratoconic. The effects on cell behaviour that loss of VIM expression may have 
had were difficult to interpret, as the protein’s function is not inherent to the monomer 
produced by the gene, but rather to the organization of the protein into filaments within the 
cells. It should also be considered that two other major cytoskeletal proteins, tubulin and 
actin, may still give the cell structure in the absence of vimentin. Of interest is that low 
vimentin expression is typically associated with poor wound repair due to myofibroblast 
impairment (Eckes et al., 2000), meaning that RA may impair wound repair response in some 
manner.  
 
The most commonly used marker of myofibroblastic differentiation for stromal cells is 
increased expression of αSMA, a contractile protein used in migration and wound closure 
(Torricelli et al., 2016). The addition of RA did alter αSMA expression, with enzyme-digested 
cells showing increased expression while explant migrated cells showed no significant 
reaction. KF did show some increased expression following RA addition, although variability 
was too high to conclude that RA significantly increased αSMA expression. In this case, KF 
seemed more similar to enzyme-digested cells rather than explant migrated cells despite KF 
being themselves explant migrated. Increased αSMA in enzdL and enzdC would suggest that 
the two cell populations are now more contractile or motile. As explant migrated cells likely 
possessed higher levels of αSMA in the first place due to their extraction method being biased 
towards more migratory cells, it may be that the gene expression was reduced to some degree 
by an inhibitor. In the future, extraction of stromal cells by explant migration could be 
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attempted with RA in order to find out if a greater number of cells can be isolated with 
potentially increased migration from the increased αSMA expression. 
 
The RARA gene codes for the non-steroid hormone receptor retinoic acid receptor α. This 
receptor is typically bound to a co-repressor complex until stimulated by RA into binding 
with a co-activator, enabling a conformational change in the receptor. This change then 
allows the RA receptor heterodimer to become a transcription factor (Cvekl and Wang, 2009). 
In the cultured stromal cells assayed, only enzdL showed an increase in RARA expression 
after addition of RA. It is possible that enzdL stromal cells are more sensitive to RA presence, 
as seen by the much greater effect of RA on proliferation. It is possible that all other stromal 
cells already possess large enough amounts of RA receptors and do not require additional 
RARA production. Analysis of RA receptors and their dimer-forming partners at the protein 
level could inform on the effects of RA on transcription factor activation.  
 
The final gene assessed, CD34, codes for a transmembrane protein. This protein is one of the 
most commonly used markers for hematopoietic and general mesenchymal stem cells lineages 
(Huss, 2000). In the cornea specifically, CD34 appears only on the stromal cells and is not 
detected on the epithelial or endothelial cells (Joseph et al., 2003). When RA was added to the 
serum-free cultures of stromal cells, CD34 expression was found to be lower in both explant-
migrated and enzyme-digested limbal cells. While central cells and KF also seemed to have 
decreased levels of CD34, no statistical significance was detected. This decrease in CD34 
could suggest differentiation and a shift in cell behaviour where limbal cells are more 
affected. This is somewhat in line with previous work that identified the limbal stroma as a 
stem cells niche.  
 
Overall, the addition of RA was hypothesized to have multiple effects based on the new 
patterns of gene expression seen. RA seemed to stimulate greater ALDH3A1 production, 
which may protect the stromal cells from UV and oxidative stress. Important shifts in ECM 
maintenance and production where identified with more KERA and less DCN being 
expressed, suggesting a greater impact on fibrillar spacing and less control on fibril diameter. 
This is further supported by lower collagen type V expression, another controller of collagen 
fibril diameter. The degradation of matrix also seemed to be altered with MMPs gene being 
most affected in explant migrated cells. While exmC and exmL seemed to have different 
MMP expression profiles, the end results seemed similar due to increased expression of 
MMP-regulator TIMP1 in exmC. Cell contractility and cytoskeleton-related genes also 
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showed change with lower expression of cytoskeleton fibril monomer and greater expression 
of genes expressing αSMA. RARA and CD34 showed more change in limbal cells, 
suggesting that the limbus is host to cells that are more sensitive to environmental cues. 
Finally, while the theory that keratoconic cells are “limbal-like central cells” held promise 
when looking at changes in ALDH3A1 and αSMA expression, KF did show some differences 
from limbal cells in genes such as CD34 and DCN. The theory of poor limbal differentiation 
being a mechanism of keratoconus remains to be investigated. With the relative success of 
keeping keratoconic cells alive in serum-free conditions as well as causing gene expression 





 Chapter 6: Engineering a 3D Culture System 
1. Abstract 
Collagens within the stroma are responsible for the cornea’s three most important attributes: 
transparency, light refraction and physical protection of the eye. The fibrillar collagen, 
produced by the stromal cells, is also thought to guide cell behaviours such as migration or 
alignment. The ECM collagen’s properties and the behaviour of cells within affect and 
maintain each other (reciprocal arrangement) to such a degree that separating the two 
undoubtedly prevents proper function. Therefore, the construction of a stromal model should 
incorporate ECM to some degree to better reproduce in vivo cell behaviour. Fibrillar collagen 
type I was used to make compressed collagen gels (CCG), this collagen type was used to 
construct the model due to its natural abundance and structural importance in the human 
cornea. CCGs were chosen as a culture system due to their relative ease of manipulation, 
similarity to in vivo ECM (in terms of collagen type I content) and extensive previous 
research on use in cell culture. The culture system made using CCG and retinoic acid (RA) 
allowed for culture of healthy and keratoconic stromal cells for extended periods of time with 
gene expression similar to what may be observed in vivo. The addition of curvature as an 
environmental cue was also shown to have some effect on cell behaviour in the gels. 
 
2. Introduction  
2.1. Stromal architecture and function 
The corneal stroma is a rigid and transparent piece of tissue that fulfils two primary functions: 
refraction of light and protection of the eye’s inner contents. These functions are achieved 
through the organization of the collagen ECM, a highly organized and well-maintained tissue. 
Within the stroma are stacked collagen lamellae and inside these lamellae collagen fibres 
arranged parallel to each other. Typically, the fibres of adjacent lamellae will be ordered in 
different directions. Overall, the stromal collagen shows two preferred orientation orthogonal 
to each other. This results in an anisotropic stress response where the tissue shows less 
deformation when subjected to stress in the vertical direction (Xue et al., 2018). The fibrils in 
the cornea do also change shape as they near the limbus, fusing with the circumferential 
collagen (Meek and Boote, 2004). Cells and their products regulate collagen fibril nucleation, 
diameter and spacing in these lamellae. This is important as is avoids fibrosis, which would 
cause opacity. Proteoglycans like decorin or keratocan, other collagens like collagen type V 
and even MMPs are used to constantly remodel the stromal ECM (Holmes et al., 2018). 
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While the cells influence the matrix, the ECM also drives particular cell behaviour. Previous 
research has found that fibre’s alignment, pressure, stiffness, and curvature all affect stromal 
cell behaviour (Gouveia et al., 2017, Kivanany et al., 2016). The construction of a stromal 
model should aim to reproduce the features exhibited by the natural tissue and improve upon 
the well appreciated limitations of traditional cell culture. 
 
2.2. Influence of stromal ECM on cell behaviour 
Previous isolations of stromal cells from the cornea found that some of the cells were capable 
of a large number of population doublings while still retaining the ability to produce essential 
components like keratocan (Du et al., 2005). In culture, these cells where capable of 
producing small amounts of stromal ECM but did not arrange this matrix into a functional 
tissue (Du et al., 2007). Spatial cues from whatever substrate the cells reside on likely 
provides the signals required for ECM organization into stromal tissue. The effects of aligned 
substrates has previously been investigated and it was found that on top of aligning cells, the 
ECM produced was made up of aligned fibrils with uniform diameters and regular 
interfibrillar spacing (Wu et al., 2012). This collagen architecture broadly replicated what can 
be seen in stromal lamellae, although the tissue lacked the curvature of the healthy cornea. 
 
2.3. Use of collagen gels in model building 
The most intuitive approach to biological model building is often to simply mimic the tissue 
architecture and properties found in vivo and then seeding primary cells within. This approach 
seemed very feasible, as the corneal stroma can be considered a simple thin disk of collagen 
matrix. Some specific features of the stroma are not easily duplicated though; the alignment 
of collagen fibrils and the very high density of collagen prove more complicated. One of the 
first attempts at using collagen precipitated from acetic acid found that these structures 
produced resembled matrix in natural mammalian soft-tissue (Elsdale and Bard, 1972). The 
application of this collagen gel-making method to the manufacture of stroma-like ECM 
produced a matrix where stromal cells organized in similar fashion to their in vivo 
counterparts (Minami et al., 1993). Newer approaches to tissue models found that 
compressing the collagen gel (Brown et al., 2005) allowed for mechanical properties that 
more closely resemble stiff tissue, such as skin or bladder (Hu et al., 2010, Engelhardt et al., 
2010). Applying compression to the precipitated collagen gels produced material with better 
light transmittance and mechanical properties as well as more hospitable conditions to corneal 
epithelial and stromal cell (Kong et al., 2017, Mi et al., 2012). Compressed collagen gels or 
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CCGs present an attractive scaffold within which to culture stroma cells and model the native 
tissue. 
 
2.4. Curvature as an environmental cue 
Using substrate curvature alone to influence cell behaviour has been done for over a decade 
(Smeal et al., 2005). In most cases, cell alignment or direction of cell growth is affected. 
Somewhat recently, the effects of curvature on corneal stromal cells were studied and is was 
found that monolayers cultured on top of a domed surface would have aligned cells producing 
aligned ECM (Gouveia et al., 2017). Utilizing the curvature of the initial scaffold, as a cue to 
pattern cell alignment and subsequent ECM production is not only simple, it also creates a 
dome-shaped tissue very similar to the corneal stroma itself.  
 
2.5. Model specifications and requirements 
Traditional technologies are normally required to fulfil specific performance requirements. In 
tissue engineering and modelling, attempts have been made to develop similar standards. 
Typically, these standards involve recognising in vivo behaviour and applying these to a 
design-build-test framework. The initial design and build phases are simple enough, but the 
testing phase is where a model should prove its efficacy and then inform on any further 
designing. When it comes to keratoconus, the main characteristics verified in testing are: 1) 
stromal ECM thinning and 2) opacity in the cornea. A keratoconic model’s success should be 
gauged by how well it reproduces these two criteria. The gene expression patterns and cell 
survival can inform on how pathologically the KF are behaving, informing on whether the 
model is suitable for any future research. 
 
2.6. Aims 
To construct a model of keratoconus in vitro, stromal cells need to be cultured in an 
environment that mimics the natural stroma. To this end, compressed collagen gels were used 





3.1. Gel making and cell encapsulation 
Healthy and keratoconic cells were encapsulated in compressed collagen gels as described in 
chapter 3, section 1.10. The resulting compressed collagen gels (CCG) were cultured in 
serum-free medium, the survival of the cells within was monitored using Alamar blue and the 
gene expression was assayed with qPCR after a month of culture.  
 
3.2. Curved gel culture 
To curve gels, freshly made CCGs containing stromal cells were gently detached from their 
original plate and draped over a glass dome of 10mm diameter. A metal washer was used to 
hold the gel in place during culture to prevent movement during feeding or plate movement. 
 
3.3. Retinoic acid supplementation 
To evaluate the effects of retinoic acid on cell survival, RA was added to serum free medium 
at a concentration of 0.5μM after being initially diluted from a powder stock (Merck, USA) to 
a concentration of 10mM in ethanol. 
 
3.4. Stromal cell gene expression in compressed collagen gels 
Following 30 days of culture, the gels were homogenized using 1ml Trizol and a syringe. 
Then 200μl of chloroform was added to the homogenized mixture and allowed to it for 15 
minutes at room temperature. After this initial phase separation, the homogenized mix was 
centrifuged at 18000xG for 15 minutes. The mix was now separated into 3 phases; the top two 
phases containing genetic material were collected for RNA isolation and suspended in 
ethanol. RNA was extracted from the cells using the RNeasy Mini Kit (QIAGEN, UK) 
according to manufacturer specifications. The RNA was then treated with DNase to eliminate 
genomic DNA. Quality assessment of the RNA was performed using a Nanodrop 2000 
spectrophotometer (Thermo Scientific, UK) to ensure the A260/A280 ratio was within the range 
of 1.7 to 2.0 and the A260/A280 was above 2:1. The RNA was then reverse-transcribed into 
cDNA with the RT2 First Strand kit (Qiagen, UK) according to manufacturer specifications in 
a TC-Plus thermal cycler (Techne, Staffordshire, UK). The resulting cDNA was then assessed 
using the Nanodrop to ensure purity and suitable concentration. The qPCR reaction was 
carried out using direct dye binding in the Eco Real-Time PCR System (Illumina, USA) and 
the appropriate primers (Table 1). The following cycles: 10 minutes of denaturation at 95°C, 
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followed by 40x cycles of 10 seconds at 95°C, 30 seconds at 60°C and 15 seconds at 72°C. 
All values correspond to average ± SD of 3 independent experiments with expression of each 
gene of interest normalized to housekeeping gene GAPDH. 
 
4. Results 
4.1. Survival of healthy and keratoconic stromal cells in gels 
 Stromal cells cultured in CCG perished at slower rates than cells seeded in identical amounts 
on flat plastic. After a month of culture in the collagen discs, the limbal, central and 
keratoconic cells all kept a population number above 40% of the initially seeded cells and 
with population numbers above 60% within the first 11 days (Fig. 12A, B and C). This 
contrasted with the 2D cultures where 50% remaining cell population or lower would be 
reached within 11 days for all cell types assayed (Fig. 6). It could therefore be said that CCG 
culture increased cell survival. 
The addition of RA further improved the survival of stromal cells, bringing the final surviving 
percentage after 30 days of culture to around 80%. No difference in cell number during the 
first 11 days could be identified between CCG culture with and without RA. This is unlike 2D 
cultures where RA had an almost immediate positive effect on the cells (Fig. 9). Statistical 
comparison of serum-free conditions with and without RA for each cell type showed a 
significant difference in cell population when RA was added: enzdL with an overall p value 
of <0.0001, enzdC with a p value of 0.0036 and KF with a p value of 0.0113. Notably, all 
three cell types assayed: limbal, central and keratoconic, showed a population percentage that 
did not change much during the final week of culture, suggesting perhaps that a stable group 
of cells was established and could survive long term as was shown previously with limbal 






Figure 12: Survival of Keratoconic cells and enzyme digested limbal and central stromal 
cells in CCG with and without retinoic acid in serum- free medium as quantified by 
Alamar blue assay. Corrected p values (<0.05) calculated by ANOVA. Data was obtained 
from 3 experiments (n=3) per cell type, each with a different donor. 
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4.2. Gene expression of healthy and keratoconic stromal cells in gels 
Multiple important keratocyte markers were assayed at the transcript level to determine 
whether culturing healthy stromal cells and keratoconic cells in CCGs affected gene 
expression. Results showed that CCG did have an effect on the expression profile of both 
healthy and keratoconic, with similar shifts in behaviour for both cell types. Expression of 
ALDH3 did increase significantly in limbal cells and in KFs, with the largest expressions of 
ALDH3 where observed in KF (Fig. 13N). Central cells did not show any change in ALDH3 
expression following a month of culture in CCG. Keratocan gene expression followed a 
similar pattern with increasing expression in limbal and KF cells, with a statistically 
significant difference observed in the two cell types. Central cells did seem to change their 
Keratocan gene expression in gel culture with a significantly decreased expression (Fig. 13B). 
Decorin gene expression showed some significant increase in central and KF cells but the 
greatest increase in expression was observed in the limbal cells, which had the lowest initial 
expression of Decorin in flat cultures (Fig. 13A). MMP3 expression was significantly 
increased in all cell types, with the most pronounced expression being in the healthy cells 
(Fig. 13I). Lumican gene expression was increased in limbal cells following CCG culture. 
The opposite was observed in KF where CCG culture caused a decrease in Lumican 
expression (Fig. 13C). Central cells did not appear to change their expression of Lumican 
when cultured in gels. TIMP1 expression was significantly reduced in central and KF cells 
while limbal cells showed a significant increase in expression (Fig. 13J). Much like MMP3, 
the expression of MMP1 was significantly increased in all cell types cultured in CCG, the 
largest increase was noted in central cells (Fig. 13G). It should be noted however that far 
greater fold-increases in expression where observed in MMP3 expression. Vimentin gene 
expression was increased in limbal and KF with central cells experiencing a comparatively 
slight increase (Fig. 13D). Significant increases in αSMA expression were observed in all 3 
cell types assayed, with the largest increases being in limbal and KF (Fig. 13L). RARA 
expression in 2D was highest in central cells, but culture in CCG caused expression to 
decrease significantly in these central cells until all three cell types appeared to express 
RARA at similar levels (Fig. 13M). Expression of both Collagen type I and V was very 
significantly reduced all cell types. MMP2 expression was reduced in all cell types, although 
only to a significant degree in limbal cells (Fig. 13H). This is the only MMP that didn’t see an 
increase when cultured in gels. Finally, CD34 expression was significantly reduced in all cell 
types following culture in CCG (Fig. 13K). 
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Figure 13: Fold change in gene expression for healthy limbal and central stromal cells and 
keratoconic fibroblasts cultured in serum-free medium on flat plastic for 11 days (left portion 
of graph) or within a compressed collagen gel for 30 days (CCG) (right portion of graph). 
Gene expression was normalized relative to control group of enzyme-digested limbal cells in 
serum-free medium cultured on flat plastic (left, solid blue fill). Cells assayed: enzyme 
digested limbal (blue solid fill), enzyme digested central cells (red solid fill) and keratoconic 
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(n = 3) and used one-way ANOVA to compare RA-supplemented culture to respective non-
supplemented control (* for p < 0.05, ** for p<0.005, *** for p<0.0005, **** for p<0.0001). 
 
4.3. Gene expression of healthy and keratoconic stromal cells in gels with retinoic acid 
The addition of RA to the CCG culture of enzdL, enzdC and KF caused multiple changes in 
gene expression. Results showed that CCG did influence the expression profile of both 
healthy and keratoconic, with similar shifts in behaviour for both cell types. Expression of 
ALDH3 showed a large significant increase in limbal cells while KFs showed a small but 
significant decrease (Fig. 14N). Central cells showed a significant decrease in ALDH3 
expression. Keratocan gene expression saw an increase in limbal cells but a decrease in KF 
while central cells showed a large increase following RA culture (Fig. 14B). Decorin and 
Vimentin gene expression was reduced in all cell populations upon addition of RA, mirroring 
the cell behaviour seen in 2D plastic cultures (Fig. 14A and D). The final proteoglycan 
assayed, Lumican, saw its gene expression increase for all cell types, although the largest rise 
was observed in limbal cells with a 40-fold increase while central cells and keratoconic cells 
showed 30-fold and 10-fold increases respectively (Fig. 14C). Both MMP1 and MMP3 gene 
expression was significantly reduced in all cell types when cultured in RA (Fig. 14G and I). 
MMP2 showed great variability across all repeats and no significant difference could be 
detected (Fig. 14H). The MMP regulator TIMP1 saw its gene expression increase in all cell 
types with exposure to RA (Fig. 14J). The expression of αSMA did not seem to be affected in 
any way for limbal and central cells but KF did show a significant decrease in the presence of 
RA (Fig. 14L). Expression of Collagens Type I and V was significantly increased in limbal, 
central and KF (Fig. 14E and F). Limbal cells showed the highest increases in both collagen 
types, reaching 100-fold increases. With the addition of RA, the expression of RARA did 
increase significantly in limbal cells and KF (Fig. 14M). Finally, CD34 expression increased 
significantly in limbal cell, increased in central cell, and showed no significant change in KF 
(Fig. 14K). 
 74 
Figure 14: Fold change in gene expression for healthy limbal and central stromal cells and 
keratoconic fibroblasts cultured in CCG with serum-free medium either without RA (left 
portion of graph) or with RA (right portion of graph) for 30 days. Gene expression was 
normalized relative to control group of enzyme-digested limbal cells in serum-free medium 
cultured in CCG (left, solid blue fill). Cells assayed: enzyme digested limbal (blue solid fill), 
enzyme digested central cells (red solid fill) and keratoconic cells (green solid fill). Data 
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ANOVA to compare RA-supplemented culture to respective non-supplemented control (* for 
p < 0.05, ** for p<0.005, *** for p<0.0005, **** for p<0.0001). 
 
4.3. Gene expression of healthy and keratoconic stromal cells in curved gels 
By curving the gel, the cells are cultured in, a curved CCG (cCCG) was made. The final 
addition of curvature as an environmental cue to the model did have some effects on the gene 
expression of limbal stromal cells and keratoconic stromal cells both in the absence of RA 
(Fig. 15) and in the presence of RA (Fig. 16). Expression of ALDH3 was not impacted by 
curvature in gels with no RA (Fig. 15N). EnzdL in cCCG with RA did show a significant 
decrease in ALDH3 expression compared to flat CCG with RA (Fig. 16N). Keratocan gene 
expression was not significantly affected by curvature either with or without RA (Fig. 15B, 
Fig. 16B), although some increase could be seen for limbal cells without RA and for KF with 
RA. Larger variability in KERA expression was observed in cCCG RA. Decorin expression 
seemed to be reduced by curvature in both KF and enzdL, though not significantly (Fig. 15A, 
Fig. 16A). Vimentin expression in the absence of RA saw a large significant decrease due to 
curvature but only for KF, enzdL had a small increase in VIM in cCCG (Fig. 15D). The 
cCCG RA did caused a decrease in VIM expression for limbal cells and an increase for KF 
(Fig. 16D). Lumican gene expression did not seem responsive to curvature in the presence of 
RA but in the absence of RA, curvature did lead to an increase in LUM expression for KF 
(Fig. 15C). Expression of MMP3 was not significantly affected by curvature in either the 
presence (Fig. 16I) or absence of RA (Fig.15I). MMP1 expression was significantly reduced 
by CCG curvature but only in the presence of RA (Fig. 16G), this effect of curvature could 
not be observed in the absence of RA (Fig. 15G). This suggests that curvature had an effect 
on MMP1 that RA enables. MMP2 was significantly increased for both enzdL and KF in 
cCCG but in cCCG RA (Fig. 15H), enzdL saw a decrease while KF saw no change (Fig. 
16H). This suggests that curvature influenced MMP2 that RA was then able to prevent. The 
last actor in the metalloproteinase-related genes assayed, TIMP1, saw its expression 
significantly decrease in both enzdL and KF in cCCG (Fig. 15J). In cCCG RA however, only 
enzdL showed a significant decrease compared to CCG RA (Fig. 16J). Curvature increased 
the expression of Collagen type I in enzdL but only in cCCG without RA (Fig. 15E). 
Expression of Collagen V was significantly increased by curvature in both enzdL and KF 
(Fig. 15F). In cCCG RA, neither of the collagen gene expression were affected. The 
expression of αSMA was reduced in KF in in the absence of RA (Fig. 15L) but increased in 
the presence of RA (Fig. 16L). EnzdL expression of αSMA was not affected by curvature in 
the absence of RA (Fig. 15L) but saw a decrease in the presence of RA (Fig. 16L). This 
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difference in αSMA shows that the two cell types are not identical. Expression of RARA 
increased in KF but only in the absence of RA (Fig. 16M). No change in was seen in RARA 
expression in the presence of RA (Fig. 16M). Finally, expression of CD34 increased in KF by 
curvature in the absence of RA (Fig. 15K) while the presence of RA lead to a decrease in 






Figure 15: Fold change in gene expression for healthy limbal stromal cells and keratoconic 
fibroblasts cultured either in flat CCG (left portion, denoted by solid line) or in curved CCG 
(right portion, denoted by solid line). Each type of gel was subjected to culture without RA. 
Gene expression was normalized relative to control group of enzyme-digested limbal cells in 
serum-free medium cultured in CCG (leftmost, solid blue fill). Cells assayed: enzyme 
digested limbal (blue solid fill) and keratoconic cells (green solid fill). Data (mean ±SD) were 
obtained from three independent experiments (n = 3) and used one-way ANOVA to compare 
RA-supplemented culture to respective non-supplemented control (* for p < 0.05, ** for 
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Figure 16: Fold change in gene expression for healthy limbal stromal cells and keratoconic 
fibroblasts cultured either in flat CCG (left portion, denoted by solid line) or in curved CCG 
(right portion, denoted by dotted line). Each type of gel cultured with RA. Gene expression 
was normalized relative to control group of enzyme-digested limbal cells in serum-free 
medium cultured in CCG (leftmost solid blue fill of Fig. 15). Cells assayed: enzyme digested 
limbal (blue solid fill) and keratoconic cells (green solid fill). Data (mean ±SD) were obtained 
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supplemented culture to respective non-supplemented control (* for p < 0.05, ** for p<0.005, 




5.1. Comparison of 2D to CCG culture 
The corneal stroma is a transparent spherical cap of highly organized collagen maintained by 
the stromal cells within. When constructing a tissue model, the cells, ECM and secreted 
factors are the three most basic quantities to consider. The cells were first approached with 
regards to their isolation method and what may constitute a proper healthy control. The 
secreted factor or the stroma were reproduced to some extent by omitting serum and adding 
factors such as ascorbic acid, ITS and RA. Finally, the ECM portion was approached with 
simple compressed discs of collagen, CCG. With its well documented compatibility with 
fibroblasts and similarity to the tissue of origin, collagen type I was the obvious choice for a 
simple culture scaffold (Sheu et al., 2001). Within these disks, the stromal cells behaved very 
differently than when cultured on tissue-culture plastic (TCP). Survival was the most striking 
change with a greater percent of the initially seeded population surviving in the serum-free 
medium. Previous culture on TCP showed that on average, 50% of cells would perish in the 
first 11 days while in CCG, none of the assayed cell population saw a drop below 60%. Even 
after a month of culture, no population, healthy or keratoconic, dropped below 40%. 
Although, there still remained a decrease in cell population, even with culture in these gels. 
Addition of RA to the medium further enhanced cell survival with central, limbal and 
keratoconic cells all retaining significantly larger populations after 30 days. In most cases, 
more than 80% of the initially seeded population survived. Interestingly, in reaction to the RA 
population growth no longer seemed occur in the CCG as it had in 2D. Instead, RA 
maintained a population of cells alive within the gels over the full month they were assayed. It 
is likely the cells could have survived even longer. This is promising as it is expected that 
cells in vivo are not constantly growing in number, rather they are maintaining a stable 
population through controlled division and apoptosis. 
 
While a positive effect on survival is encouraging, there remained the issue of gene 
expression profile for the three cell types: central, limbal and keratoconic. The principal 
protective protein in the cornea that offsets oxidative stress, ALDH3A1, was greatly increased 
in both limbal and keratoconic cells, although KF did show such a large amount of variance 
that the increase could not be classified as significant. This is somewhat encouraging as high 
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production of the protein could be regarded as a corneal fibroblastic behaviour. Central cells 
however, did not show any change in expression of this crucial protein. The exact reason for a 
lack of reaction on the part of central cells is unclear although it could be hypothesized that 
since central cells initially expressed the highest amount of ALDH3 prior to CCG culture, the 
cells are already at their maximum production. In the cornea, these cells are the most 
vulnerable due to their location and terminal differentiation, therefore requiring the most 
ALDH3A1 possible. The shift in ALDH3A1 expression when cultured in CCG also further 
reinforces the idea of limbal healthy cells and central keratoconic cells share an identity to 
some degree. 
 
As well as protecting themselves, the stromal cells now have an ECM to maintain as provided 
by the CCG. The production of various crosslinkers and collagens allows for an assessment of 
this activity. Keratocan showed more evidence of a similarity between limbal and KF cells, 
although this time a statistically significant difference could be observed in both cell types. 
Central cells did not seem to change their expression of KERA when cultured CCG, although 
once again the expression on KERA in flat surface culture was highest in central cells and 
may already be at it maximum, incapable of increased even when cultured in CCG. For 
central cells, this trend continues with VIM and LUM. DCN showed an increase for central 
cells but the variability was too great to draw statistical significance. In regard to crosslinker 
production (KERA, VIM, LUM and DCN), central cells seemed to outperform limbal and 
keratoconic cells on flat surface culture but shows little to no reaction to the new CCG 
environment. Limbal cells on the other hand showed great reactivity in regard to production 
of the four crosslinkers when cultured in CCG. Along with the previously mentioned KERA 
increase, LUM, VIM and, DCN all significantly increased. It appears that limbal cells have a 
greater capacity for change in regard to the strengthening of existing matrix. The changes in 
regard to environmental cues suggest a less differentiated state with room for adaptation 
rather than a fixed set of gene expressions, as observed so far in central cells. Keratoconic 
cells initially seemed to follow limbal cells by increasing KERA, VIM, and DCN expression 
when cultured in CCG, although the DCN increase was not significant due to large variance. 
However, LUM expression was found to drop in KF following CCG culture. Since these KF 
are diseased cells, showing a loss of expression in one of the important proteoglycans for 
corneal functions could be seen as encouraging in regard to model building. Although 
whether this is the correct kind of pathological behaviour remains to be seen. Expression of 
collagen type 1 and 5 dropped dramatically in the three cell types when cultured in CCG, it 
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stands to reason that once in ECM, the cells need not produce as much matrix to house 
themselves. 
 
Continuing in the ECM maintenance functionality of these stromal cells, expression of MMP 
and MMP-associated TIMP1 was also affected by culture in CCG. In limbal, central and 
keratoconic the expression of MMP1 and MMP3 was very significantly increased, 
particularly MMP3. Out of the three cell types, central cells appeared to yield the largest 
increase in MMP1 and MMP3 expression following CCG culture. MMP2 expression seemed 
unaffected in central and keratoconic cells but a significant decrease was observed in limbal 
cells. The MMP regulator TIMP1 saw its expression decrease in both central and keratoconic 
stromal cells while limbal cells had a non-significant increase. Overall, all stromal cells seem 
to be more active in the deconstruction of ECM following culture in ECM rather than on 
plastic which is to be expected. In this facet of ECM maintenance, KF seem to mimic limbal 
cells in the production of MMP1 and MMP3 but then appear most similar to central cells in 
the expression of TIMP1 and MMP2. With keratoconus being a disease where the corneal 
stroma loses a large portion of ECM, it could have been expected that MMP expression would 
be highest in KF and with minimal expression of the MMP-regulator. This was not the case, 
although more facets of the model remain to be explored and more factors added.  
 
In the past, it has been shown that culturing fibroblasts in a 3D environment enriches the 
mechanical activity of the cells (Rhee, 2009). With αSMA being one of the principal ways for 
cells to mechanically interact with the environment, the expression of the gene was of interest. 
In all three cell types, αSMA expression was increased. However, the increase was highest in 
keratoconic and limbal cells while central cells showed only a relatively modest 20-fold 
increase in expression. Once again, KF appeared to behave more like limbal cells than central 
cells, this time in regards to expression of a gene related to migration and contractility.  
Expression of RARA seemed to decrease in all three cell types to some degree but the only 
significant decrease was seen in central cells. There is no obvious explanation as to why 
culture of stromal cells in CCG would cause a reduction in the expression of a retinoic acid 
signalling factor. Lastly, CD34 saw a significant reduction in all three cell types assayed, 
although this is likely due to the difference in culture time between 2D and 3D cultures, the 
former lasting 11 days while the latter went on for a month. 
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5.2. Comparison of CCG with and without RA 
Addition of RA to culture medium enhanced survival of limbal, central and keratoconic 
stromal cells in CCG. Along with the increase in the percentage of viable cells, RA also 
caused some changes in gene expression. Expression of ALDH3 was increased in limbal cells 
and decreased in central cells while KF did not appear affected. The reaction of all 3 kinds of 
stromal cells in CCG was unlike that of cells cultured on flat plastic where a large increase in 
ALDH3 was observed upon addition of RA. This could mean that gel culture interferes to 
some extent with RA signalling or, considering the ALDH3 increase due to CCG culture 
alone, gel culture is sufficient to drive ALDH3 expression up to a cap in the case of KF. That 
RA did manage to greatly increase ALDH3 expression in limbal cells suggests a greater 
potential for ALDH3 production in these cells, while central cells and keratoconic cells may 
have less potential and therefore be more vulnerable to oxidative stress. The expression 
profile of keratoconic cells harvested from the limbus would prove very interesting in this 
instance to discern if a lack of ALDH3 expression is innate to all KF cells or due to a more 
central identity of the KF. However, availability of such cells is scarce and collection poses 
some issue. 
 
Expression of crosslinker genes changed in all cell types after CCG RA culture. VIM and 
DCN both saw significant drops for all cell types once RA was added to the CCG culture 
system. This mimics what was observed in 2D upon addition of RA as both VIM and DCN 
expression dropped in that instance too. LUM expression was increased in CCG by the 
addition of RA. This was unlike what had been observed in 2D where, upon addition of RA, 
LUM expression had only increased in limbal cells while decreasing in central and KF. In 
CCG, the largest increase was in limbal and central cells while KF cells showed only a very 
small increase. A larger reaction to RA in the case of LUM seems to be exclusive to healthy 
cells. This, taken in conjunction with the decrease of KF’s LUM expression upon culture in 
CCG, would suggest that LUM is a gene particularly affected in the keratoconic disease 
pathway. A deficiency in lumican production has previously been investigated as a way of 
modelling keratoconus in animals, although results proved inconclusive with no definitive 
similarities between lumican-deficient mouse corneas and keratoconic tissue (Shao et al., 
2011). Analysis of lumican at a protein level in response to RA and CCG culture would no 
doubt aid in further elucidating just how relevant this is to keratoconus. KERA expression 
was also affected with a clear healthy/keratoconic divide. In the case of KERA, limbal and 
central cells both showed increased expression while KF’s expression decreased with the 
addition of RA to the CCG. This is unlike the 2D culture system where the addition of RA 
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prompted large increases in KERA expression for all cell types. It should be noted that when 
introduced to the CCG environment, KF saw the largest increase in KERA expression, and 
with the addition of RA both healthy cells and KF now express similar amounts of KERA. In 
regards to the expression of both collagen type I and V, the two genes had their expression 
significantly increase in all donors upon addition of RA, suggesting greater ECM production 
capacity in the stromal cells. Limbal cells in particular saw the largest increase in both types 
of collagen while the healthy central and keratoconic central cells both had a smaller increase.  
 
Following the production and crosslinking of ECM, the degradation of ECM by MMP and 
associated regulators seemed to decrease as seen by the expression patterns of the stromal 
cells in CCG RA. When introduced to the CCG, MMP1 and MMP3 expressions both saw 
large increase for healthy and keratoconic cells. When RA was added to the CCG, MMP1 and 
MMP3 expression both decreased significantly. This was also accompanied by an increase in 
TIMP1 expression across all donors. While MMP2 still remained highly variable, some 
significantly higher expression was noted in limbal cells and central cells had some increase 
though not variable. Meanwhile, KF seemed to little change in MMP2 expression. In the 2D 
culture system, no decrease in the expression of MMPs could be seen upon addition of RA, 
even though past research seems conclusive that MMP1 should definitely see a reduction 
following RA addition (Pardo and Selman, 2005). Only in 3D culture, where the cells where 
stimulated to produce a larger amount of MMPs due to the surrounding ECM, could a large 
RA-induced change be seen in MMP expression.  
 
RARA expression seemed to have increased in all cell types with the addition of RA, 
although the large variance prevents any statistical significance. The increases in RARA 
expression in the presence of RA do seem more pronounced in 3D than in 2D but due to the 
large variance it is difficult to draw a conclusion regarding the effect of CCG on the cellular 
reaction to RA. When introduced to CCG, all three types of cells (enzdL, enzdC and KF) 
showed increased αSMA expression, with central cells showing only a modest increase while 
limbal and KF showed a higher increase. With the addition of RA, limbal and central cell 
expression of αSMA did not change but KF expression of αSMA now most resembles central 
cells. Finally, CD34 expression increased in the two healthy cell types but no the KF, 
although the increase in healthy central cells was too variable to be significant. This could be 
interpreted as RA maintaining some degree of cell plasticity but only in healthy cells, 
meaning that KF may not be able to possess traits typically associated with higher CD34 
expression such as progenitor localization and niche anchoring (Joseph et al., 2003). 
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5.3. Comparison of flat and curved CCG in the presence and absence of RA 
Curvature as an environmental cue has been shown to affect cell alignment and ECM fibre 
alignment. While in the past there has been evidence that curvature could affect corneal 
stromal cell gene expression, particularly ALDH3 and key crosslinkers, it was after the 
stromal cells had produced aligned matrix with mechanical and chemical properties very 
different from the planar control (Gouveia et al., 2017). In the experiment presented here, the 
cells were not allowed to produce their own matrix from a curved or planar template for 
several months before assaying gene expression (as collagen was included from the start). 
Only healthy limbal cells and KF were assayed here. The effects of RA were also assayed in 
the new curved CCG by comparing flat versus curved with RA as well as flat versus curved 
without RA. Curvature seemed to have some effect on gene expression. ALDH3 expression 
was decreased in healthy cells in cCCG relative to the flat CCG with RA. ALDH3 expression 
in KF did seem to increase although the variance meant that there was no statistical 
significance. Loss of ALDH3 would certainly expose the cells to greater oxidative stress 
where they in vivo. Additionally, this goes against the previous observation made on limbal 
stromal cells grown on a curved surface, where ALDH3 expression was found to have 
increased (Gouveia et al., 2017). The ALDH3 expression we observed on flat surface with 
RA was more in line with previous data, as an increase in expression was observed relative to 
the no-RA control. 
 
With regards to the crosslinkers, KERA saw an increase for healthy cells when cultured in 
cCCG compared to CCG, however this same increase was not noted when comparing the flat 
and curved gels in the presence of RA. In KF, a decrease was noted in KERA expression that 
once again was only seen in the absence on RA and although a much greater expression of 
KERA seemed to have occurred in cCCG RA, there was no statistical significance noted. 
DCN as well showed no difference between CCG and cCCG when RA was present but when 
comparing flat and curved gels in the absence of RA, both healthy and KF showed a decrease 
in DCN. VIM continued the pattern of RA either preventing or obscuring curvature-
stimulated expression changes as only the non-RA supplemented CCG showed a difference 
between flat and curved. In the case of VIM, a decrease was noted for KF while an increase 
was seen in healthy cells. LUM bucks the trend by showing no statistically significant 
difference whatsoever. ECM production as measured by expression of collagen types I and V 
did also seem affected by curvature. In the case of collagen type 1, increased expression was 
only seen for healthy cells in the absence of RA. In the case of collagen type V, a large 
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increase in expression was seen for healthy cells and KF when the gel was curved without RA 
present. In cCCG RA, healthy cells did show some decrease in collagen type V expression. 
While previous research on gene expression of stromal cells on curved surface is limited, the 
past data was conclusive in showing an increase in all the crosslinkers and collagens assayed 
here. It is likely that short culture, encapsulating the cells rather than culturing the cells on the 
surface, and allowing a templated ECM to form lead to these differences.  
 
The expression of MMPs and TIMP1 was also affect by curvature. Without RA and when the 
CCG was curved, decreases in MMP1, MMP3 and TIMP1 were observed in limbal cells. In 
KF under the same conditions similar decreases were noted in MMP3 and TIMP1 showed a 
marked decrease, but an increase was seen in MMP1 and MMP2. When RA was added to the 
cCCG, limbal cells saw an increase in MMP1 and MMP3 while still observing a reduction in 
TIMP1. KF in the same RA cCCG conditions only saw a reduction in MMP3. There appeared 
to be different reactions to curvature based on whether or not RA was present. The best 
example is MMP3 expression, where in the flat gels a clear anti-MMP3 effect of RA can be 
observed, but in curved gels the levels of MMP3 appear not to change when RA is added. 
MMP1 expression does show some distinct anti-MMP1 effect of RA that persists in curved, 
although to a lesser degree. It would seem that the curved CCG culture system rendered the 
stromal somewhat less sensitive to the effects of RA, whether that is an effect of curvature 
alone is difficult to ascertain.  
 
As seen is almost all other culture conditions, RARA remains a very variable expressed gene. 
However, in the cCCG without any RA present, some increase in RA-receptor’s gene 
expression was seen. Expression of αSMA showed change only in KF, where culture in 
cCCG caused a reduction, although this was not seen in cCCG RA. Finally, the improved 
limbal cell CD34 expression that was seen in flat CCG in the presence of RA could not be 
detected in curved CCG with RA. Overall, the exact effect of curvature was complex although 
there seemed to be a pattern of curvature seemingly desensitizing the stromal cells to RA, 
causing effects that were previously seen in flat gels to vanish. It remains to be seen whether 
curved or flat gels best allow the stromal cells to emulate the in vivo counterparts. 
 
One the repeating correlation seen in this experiment was the inverse relationship between 
KERA and MMP1. With almost every change in culture conditions and in all cell type, a 
decrease in KERA would coincide with a large increase in MMP1. Starting with the shift 
from 2D to 3D culture, where central cells showed no increase in KERA expression yet 
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produced the largest increased in MMP1 expression. Then, with the addition of RA to the 3D 
cultures, the same central cells showed the greatest increase in KERA and the greatest 
decrease in MMP1. When the gels went from flat to curved gels, limbal cells showed 
increased KERA accompanied by decreasing MMP1. KF experiencing the same shift from 
flat to curved showed decreasing KERA followed by increasing MMP1. Very little research 
has been done concerning the absence of KERA and its effects, although one study did find 
that KERA expression decrease did deform the cornea without affecting the expression of 
other cross-linker proteins (Liu et al., 2003). Keratocan’s role as a determinant of collagen 
fibril size and spacing is well documented, suggesting that without KERA expression fibril 
size would increase causing stromal swelling. The inverse was observed with the absence of 
KERA leading to thinner corneas (Liu et al., 2003). In the past, experiments using KERA and 
LUM knockouts found that while both produced animals with thinner corneas, only the LUM 
mutant could be suitably explained due to reduced collagen biosynthesis and lower keratocyte 
count (Chakravarti et al., 2000). Previous research showed that the expression of keratocan is 
in some way modulated by lumican, another proteoglycan of the same family (Carlson et al., 
2005). However, in our experiments KERA expression seemed to behave independently of 
increased or decreased LUM expression. It would certainly be interesting to find out if KERA 
knockout models have altered expression of MMP1, to further investigate the regulatory role 
of KERA on MMP gene expression. It is possible that the increased MMP1 expression in the 
absence of KERA is to blame for the thin corneas observed in KERA mutant animals. 
Importantly, the KERA-MMP1 correlation did not include TIMP1, the more obvious MMP 
regulator, or include the other MMPs to the same degree. It could be theorized that within the 
cornea, RA can affect MMP1 expression specifically either via KERA or through an 





Chapter 7: Validation of the Artificial Stromal Model 
1. Abstract 
Tissue engineering as a field has provided tools and techniques necessary to construct 
biological equivalents of tissues and systems found in living organisms. From this 
development of complex cell culture systems arose the field of disease modelling. This field 
provides the unique challenge of replicating faulty cell and tissue behaviours outside of the 
host environment. Having ourselves managed to culture keratoconic cells in a cornea-like set 
of conditions, it remains to be seen how valid this culture system is and how applicable it is to 
modelling use. Although healthy and keratoconic stromal cells were cultured successfully, 
some problems were notable. The expression of certain genes seen in vivo could not be 
recapitulated in vitro, particularly in the case of MMP2 and CD34. However, the combined 
use of retinoic acid and compressed collagen gels did seem to bring the gene expression 
profile of stromal cells to a state closest to that observed in vivo. With this in mind, the culture 
conditions laid out in previous chapter could be used to assemble a stromal model of 




2.1. Hallmarks of keratoconus gene expression in vivo 
The characteristics of keratoconus that were previously mentioned in the literature review 
chapter could broadly be separated into two categories: the diagnostics signs that include 
deformation, iron deposition and membrane breaks; and the molecular characteristics that 
include increased presence of inflammatory molecules or loss of ALDH3. The latter of the 
two categories constitutes behaviour that this model aims to replicate in vitro. Whether the 
model is capable of recapitulating the differences seen between healthy and keratoconic cells 
in vivo was used as a measure of this model’s success and validity. The comparison between 
healthy limbal stromal cells and keratoconic stromal cells focused particularly on the gene 
expression of: crosslinker proteins, ALDH3A1, MMP and collagen. Each of these has been 
reported as dysregulated in the keratoconic cornea.  
Keratocan is an abundant proteoglycan found in the corneal stroma and is responsible for 
collagen fibril size and spacing. The expression of keratocan is closely tied to lumican, 
another proteoglycan of the same family (Carlson et al., 2005). Keratocan is exclusive to the 
cornea and its expression is considered a marker of keratocyte function (Foster et al., 2014). 
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Reports state that keratocan along with other crosslinking proteoglycans such as vimentin and 
decorin, are all upregulated in the keratoconic stroma albeit with some molecular structural 
alterations (Funderburgh et al., 1998, Yam et al., 2019).  
The loss of collagen is another change in the stromal environment. Whether this is due to 
increased enzyme activity, decrease in collagen production or shift in type of collagen 
produced is uncertain, although all three of these characteristics have been observed at some 
point in keratoconic corneas. Increased collagenase and gelatinase activity in keratoconic 
corneal buttons have been noted for a long time (Kao et al., 1982, Rehany et al., 1982). With 
further research, the implications of the inflammatory system became clearer, although the 
exact sequence of events is still unclear and interleukins may play either an initiating or 
supporting role (Balasubramanian et al., 2010). With regards to collagen production, an 
obvious shift is seen in the case of scar tissue, where collagen type III is more abundant that 
the usual collagen type I (Newsome et al., 1981). However, scars are a secondary 
consequence of keratoconus rather than part of the disease itself. Normally present in the 
healthy stroma is collagen type V, an intermediary linker and spacer for collagen type I 
fibrils. In keratoconus, collagen type V reportedly sees a marked decrease (Chaerkady et al., 
2013). 
In regards to enzyme production, increased expression of MMP genes and the activity of the 
produced proteins have been noted on several occasions. Accompanying this increase in 
proteolytic activity is a decrease in regulatory protein activity, particularly TIMP-1 
(Balasubramanian et al., 2010). The collagenase MMP1 has been reported as showing 
increased expression (Seppala et al., 2006), targeting collagen types I and III in particular 
within the stroma. Stromelysin MMP3 has been reported as showing no significant difference 
in its keratoconic gene expression relative to a healthy control (Saghizadeh et al., 2001). 
Gelatinases like MMP2 have also been investigated as a culprit of matrix degradation since 
some native collagens like collagen type IV and V are vulnerable to the enzyme. Bowman’s 
layer in particular would be a target due to its higher collagen type IV content and since 
breaks in this layer are a hallmark of keratoconus, investigating gelatinase is relevant (Collier, 
2001). Previous research did find that MMP2 expression was not significantly increased and 
the produced enzyme was mainly found in its inactive state (Fini et al., 1992). The enzyme-
regulator TIMP1 showed a decrease in expression in keratoconic corneas (Kenney et al., 
2005). Interestingly, TIMP1 polymorphisms have been correlated with keratoconus incidence, 
meaning that while any change in expression may not reflect protein function, in this case it is 
a particularly applicable consideration (Saravani et al., 2017). 
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Nuclear retinoic acid receptors are divided in two classes: RXR and RAR, which bind 
together to form a heterodimer involved in the detection of retinoic acid. Mutant mice lacking 
the expression of either RXR or RAR showed abnormal corneal development and 
deformations (Kastner et al., 1994). While the gene hasn’t been tied to keratoconus and its 
expression hasn’t been extensively studied, it remains a gene of interest (Rong et al., 2017). 
The activation of keratocytes into myofibroblasts is characterized by the increased expression 
of alpha smooth muscle actin (αSMA). The contractile myofibroblasts are essential to wound 
closure as they may bridge the wound gap and pull the edges together. Myofibroblasts, like 
other corneal stromal cells, will produce ECM crosslinkers and MMPs to remodel damaged 
stroma (Ebihara et al., 2007). Myofibroblasts play an essential role in wound healing of the 
cornea, however these differentiated cell states are also associated with pathological processes 
like corneal haze and scarring (Connon et al., 2003). In keratoconus, no major association 
with αSMA has been established although the gene itself remains an excellent marker of cell 
identity. 
Through cataloguing these established gene expression hallmarks of keratoconus, it may be 
possible to judge a disease model’s worth in reproducing these characteristics. 
 
2.2. Previous keratoconus models and their validity 
The strict definition of a disease model is typically: an animal or cells that will display all or 
some of the pathological processes that can be normally be observed in human patients. The 
purpose of the disease model is to aid in understanding how the disease develops and provide 
testing for potential treatment. In the work presented here, the model is a population of 
keratoconic cells that have been submitted to conditions similar to those they would be in 
vivo. When healthy cells were submitted to the same conditions, they adopted gene expression 
and survival behaviour similar to what may be observed in vivo. While this culture system 
seems able to model the corneal stroma, its validity in regards to modelling keratoconus 
remains in question.  
Like almost all in vitro models, keratoconus began its in vitro studies as a simple monolayer 
of primary cells and the initial investigations with this system found that the keratoconic 
stromal behaved differently in culture, particularly in the production of some cross-linkers 
and collagens (Yue et al., 1979). Further work then aimed to reproduce features of the stromal 
environment in an attempt to mitigate the effects of culture on keratoconic cell behaviour 
(Gouveia and Connon, 2013). These features included serum-free medium and supplements 
like retinoic or ascorbic acid and lead to further discoveries regarding the gene expression and 
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protein secretion of the cells. Some work was done with non-primary cells in order to 
overcome the need for a reliable source of donor tissue. One example is the use of induced 
pluripotent stem cells (iPSC) combined with viral reprogramming to yield cells with 
keratoconic features (Joseph et al., 2016). How reliable this approach is with regards to 
reproducing the molecular and cell interactions of keratoconus is debatable, although the 
benefits of easy availability are obvious. For the sake of this experiment, primary cells were 
used as tissue was readily available and any model-building effort benefits from having 
components from the originally studied system. The next obvious consideration was that the 
cornea itself is a large piece of tissue composed of multiple layers of ECM assembled by the 
cells within and its properties are determinants of cell behaviour. While the construction of 
healthy corneal models has progressed to a point where multilayer tissues have been 
constructed with relative success, the keratoconic cornea has had few attempts at modelling in 
a 3D manner. A model of keratoconus was a constructed using cell-generated matrix to 
investigate the relevance of 3D culture on the modelling of keratoconus (Karamichos et al., 
2012). Although the culture in question used serum medium, convincing evidence showed 
that a 3D culture system caused drastic changes in cell behaviour and may be more desirable 
in future modelling of keratoconus. 
The validity of these models was assessed by how well particular characteristics of 
keratoconus were reproduced in vitro and how closely the cell environment resembled the in 
vivo conditions. Similar criteria were used to judge the validity of the model built in our 
experiments. Importantly, the model was compared to two ethnic groups of keratoconus 
patients: European Caucasians and Saudi Arabian Arabs. The different incidence of the 
keratoconus suggests potentially different genetic profiles for the disease. Comparing the 
model to two different profiles also helps in deciding the future development that may be 
taken in refining the model. 
 
2.3. Aims 
Having assembled a 3D culture system for healthy and keratoconic cells, it remained to be 
seen how well the disease behaviour and corneal environment could be replicated. To assess 
these criteria, qPCR of healthy cells immediately after extraction was used as a baseline to 
which set of culture conditions was compared. This allowed us to find the set of culture 
conditions that best enable the natural stromal cell expression. As a second measure, RNA-
Seq was used to compare keratoconic cells grown in our model to keratoconic harvested from 
patients. The degrees of similarity between the two may be interpreted as a measure of the 




3.1. Quantitative PCR 
RNA had previously been collected from healthy enzyme-digested limbal stromal cells 
(enzdL). This included RNA isolated directly after cell isolation (enzdL FRESH) as well as 
RNA isolated after culture in conditions described over the course of the previous chapters 
(RA, CCG, cCCG). Quality assessment of the RNA was performed using a Nanodrop 2000 
spectrophotometer (Thermo Scientific, UK) to ensure the A260/A280 ratio was within the range 
of 1.7 to 2.0 and the A260/A280 was above 2:1. The RNA was then reverse-transcribed into 
cDNA with the RT2 First Strand kit (Qiagen, UK) according to manufacturer specifications in 
a TC-Plus thermal cycler (Techne, Staffordshire, UK). The resulting cDNA was then assessed 
using the Nanodrop to ensure purity and suitable concentration. The qPCR reaction was 
carried out using direct dye binding in the Eco Real-Time PCR System (Illumina, USA) and 
the appropriate primers (Table 1). The following cycles: 10 minutes of denaturation at 95°C, 
followed by 40x cycles of 10 seconds at 95°C, 30 seconds at 60°C and 15 seconds at 72°C. 
All values correspond to average ± SD of 3 independent experiments with expression of each 




Three donor cell lines of keratoconic stromal cells were cultured in curved collagen gels with 
retinoic acid for 30 days before the RNA was extracted and quantified as previously 
described. Dr. Shukti Chakravarti and her group as part of an on-going collaboration then 
processed these 3 samples. The sequenced RNA bulk data was then returned along with data 
from keratoconic patients (12 middle-eastern and 3 European). The sample group of cultured 
cells was then compared to each of the two patient sample groups to assess model 
transcriptome similarity to patient transcriptome. The method used was: FastQC version 
0.11.8 (and multiqc) for read quality control, Salmon version 0.14.1 for mapping to the 
human (hg38) transcriptome and DESeq2 bioconductor version release 3.9 for differential 
expression analysis. Cutadapt 2.4 was used to trim Illumina sequencing adaptors. 
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4. Results  
4.1. Quantitative PCR 
The purpose of this comparison was to identify which set of culture conditions could best 
reproduce the gene expression seen in the freshly extracted cells. This was used as a measure 
of how well our environmental conditions are stimulating cell in vitro to behave like the in 
vivo source population. Results showed that no one set of culture conditions could force the 
cells to behave like the freshly extracted baseline. However, some conditions did come closer. 
CCG RA in particular caused the stromal cell’s expression of 11 out of 14 assayed genes to 
not be statistically different from the fresh stromal cells. Limbal stromal cells cultured in flat 
compressed collagen gels and fed with serum-free medium supplemented with retinoic acid 
behave mostly like the same cells in their native environment. There were some genes whose 
expression could not be returned to in vivo levels: CD34, MMP2 and KERA. In the case of 
CD34 and MMP2 in particular, the levels plummeted and never recovered no matter the 
culture conditions (Figure 16). KERA expression did show varying degrees of recovery with 
CCG RA coming the closest to the original expression levels, although the difference 
remained significant. In almost every culture condition, retinoic acid had a positive effect on 
the gene expression of the limbal stromal cells. Comparing SF and SFRA as well as CCG and 
CCG RA, we can see that the number of genes expressed significantly differently decreases, 
from 7 to 5 in SF and 7 to 3 in CCG (Table 2). Retinoic acid certainly seems to be a most 
effective supplement with 3D culture further empowering the effect. 
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Figure 17: Gene expression of enzyme-digested healthy limbal stromal cells in various culture 
conditions relative to freshly extracted limbal stromal cells. The model conditions are: SF = serum-free 
medium only, CCG = compressed collagen gel, cCCG = curved CCG. RA indicates the presence of 
retinoic acid in the culture medium. 
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 SF SF RA CCG CCG RA cCCG 
cCCG 
RA 
DCN 0.003 0.015 0.070 0.281 0.011 0.022 
ALDH3A1 < 0.0001 0.785 < 0.0001 0.387 < 0.0001 < 0.0001 
aSMA 0.277 0.295 0.285 0.200 0.311 0.326 
VIM 0.160 0.509 0.093 0.599 0.043 0.116 
MMP3 < 0.0001 0.480 0.145 0.576 0.142 0.142 
MMP1 0.777 0.430 0.085 0.662 0.053 0.081 
KERA < 0.0001 < 0.0001 < 0.0001 0.013 0.007 < 0.0001 
COL1 0.091 0.138 0.315 0.107 0.109 0.057 
COL5 0.160 0.017 < 0.0001 0.521 0.871 0.167 
RARA 0.008 0.464 0.003 0.089 0.141 0.001 
TIMP1 0.319 0.117 0.247 0.196 0.908 0.181 
MMP2 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
CD34  < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
LUM 0.344 0.093 0.167 0.151 0.192 0.053 
Table 2: Results of multiple t-tests comparing the freshly isolated limbal stromal cells to the cells 
cultured in the various model conditions (SF = serum-free medium only, CCG = compressed collagen 
gel, cCCG = curved CCG) RA indicates the presence of retinoic acid in the culture medium. Hexes 






















Initially principal component analysis (PCA) was used to identify general differences in 
transcription profile (Fig. 17). As was expected, cells from similar patient groups and cells 
cultures in the model each formed their own cluster and it is clear that the model shows some 
differences from both patient samples.  
 
 
Figure 18: Principal component analysis showing transcriptional variance among the two 
patient groups and the model, with the model being the most different. European Caucasian 
keratoconus patients in blue, Saudi Arabian keratoconus patients in red, model samples in 
green. 
 
Analysis showed that out of the 41256 genes expressed in the both the European patients and 
model samples, 15446 genes were expressed significantly differently than in the model (Fig. 
18B and 18D). Among those differently expressed genes, 6511 were reduced while 8935 were 
increased. Comparing the Saudi patients and models samples showed 41241 genes expressed 
in both with 17498 genes expressed differently than in the model (Fig. 18A and 18C). Among 
those differently expressed genes, 7420 were reduced while 10078 were increased. In both 
cases, a greater variety of gene seem to be highly expressed in the patients than in the model. 
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Figure 19: Heat map of all significantly enriched (blue) and depleted (red) genes for: (A) 
Saudi Arabian patient samples (red) vs model (green) and (B) European Caucasian patient 
samples (blue) vs model (green). Volcano plots DESeq2 analysis of: (C) Saudi Arabian 
patient samples vs Model samples and (D) European Caucasian patient samples vs Model 
samples. 
 
Having deduced that the model’s keratoconic cells are overall very different from the 
patient’s keratoconic cells and that fewer genes are highly expressed in the models, specific 
genes of interest can now be identified for further investigation. 
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 European Caucasian vs Model Saudi Arabian vs Model 
Gene p value log2 Fold Change p value log2 Fold Change 
DCN 0.044927125 -1.178472402 3.29E-08 -3.496993351 
ALDH3A1 0 13.46295866 0 13.63122549 
aSMA 1.59E-30 -7.023091821 4.69E-41 -6.525173326 
VIM 0.006896053 -1.868566265 6.44E-08 -3.694583534 
MMP3 0.406381146 -0.582736576 0.004436869 -3.028269 
MMP1 0.001424595 -4.092874712 4.52E-10 -8.5558165 
KERA 0.390831194 -0.477554619 0.00276404 -1.889882 
COL1 α2 chain 5.04E-06 -6.996375 1.52E-05 -5.03760894 
COL5 α3 chain 2.40E-13 -6.286702246 1.89E-25 2.943493325 
RARA 0.00176206 -0.831695125 5.21E-13 -1.602180527 
TIMP1 5.65E-56 -6.154045006 2.84E-94 -6.385010565 
MMP2 6.53E-08 -7.730155267 4.61E-08 -6.417490231 
CD34 0.050206499 1.203552768 0.9851764 -0.008425096 
LUM 1.13E-05 -3.916611417 2.27E-09 -4.501190344 
Table 3: Fold change and associated p value for genes of interest as gathered by RNA-Seq 
comparing model samples and each of the two patient groups. Non-significant p values 
(>0.05) are highlighted. 
  
The genes initially investigated in qPCR expression analysis were also investigated in RNA-
Seq (Table 3). Caucasian patients expressed similar levels of KERA, MMP3 and CD34 to 
what was seen in models. In Arabic patients, only CD34 was expressed at similar levels to the 
model. ALDH3A1 in particular showed much greater expression in the patient groups than in 
the model. Genes that are commonly associated with matrix degradation like MMP1, MMP2 
and MMP3 were less expressed in the patient groups, with the exception of MMP3 in 
Caucasian patients. While the patient groups seemed to have generally similar correlations 
relative to the model, some genes had an increasing fold change compared one patient group 
and a decreasing fold change compared to the other patient group. Collagen type V for 







log2 Fold Change p value Gene name Gene description 
-19.88976747 1.93E-08 RXRB retinoid X receptor beta 
-8.690919235 3.28E-08 RARRES2 retinoic acid receptor responder 2 
-10.19005893 2.13E-36 ACTG2 actin, gamma 2, smooth muscle, enteric 
-9.798855765 1.02E-16 CRYGN crystallin gamma N 
12.9455653 1.35E-28 CRYBG2 crystallin beta-gamma domain containing 2 
25.03310458 7.52E-23 HSPA1B heat shock protein family A member 1B  
Table 4: Selection of European Caucasian patient genes that showed particularly large fold 
changes relative to the model.  
 
log2 Fold Change p value Gene name Gene description 
-9.340588868 1.26E-10 RXRB retinoid X receptor beta  
-9.692303314 5.29E-45 CRYGN crystallin gamma N  
13.04666632 9.61E-30 CRYBG2 crystallin beta-gamma domain containing 2  
26.14215665 6.64E-18 HSPA1B heat shock protein family A member 1B  
Table 5: Selection of Saudi Arabian patient genes that showed particularly large fold changes 
relative to the model. 
 
As RNA-Seq allows for the identification of a very large number of transcribed genes, it was 
possible to look through the significantly different results for interesting genes where 
expression showed large fold changes. These genes are the outliers particularly visible in 
Figure 18C and 18D. When initially surveying the data, large changes could be seen in 
numerous keratin genes relative to the model. This suggests that the patient sample contained 
epithelial cells, as epithelium the main producer of this particular protein and stromal cells 
produce relatively little keratin. Two crystallins were found to be expressed very differently in 
the model relative to the patient samples: crystallin gamma N and a member of the crystallin 
beta-gamma family, with the former being more expressed in the model while the latter is 
more expressed in the patient samples. HSPA1B, a member of the HSP70 family of 
chaperone proteins also showed greater expression in patients than in the model. Retinoic acid 
associated proteins had their gene expression show up as lower in the patients than in the 
model. Finally, another smooth muscle actin, ACTG2 was shown to be expressed more in the 
model. 
 
5. Discussion  
By using freshly extracted limbal stromal cells as a baseline and comparing the gene 
expression of the same limbal cells cultured in various conditions we have found what set of 
conditions cause cells to behave most like the in vivo counterparts. The most obvious 
weaknesses of this validation method are: 1) that this method involved healthy and not 
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keratoconic cells; and 2) that all we have shown is that CCG RA as a culture condition can 
stimulate healthy behaviour from healthy limbal stromal cells. As the aim of our work was to 
design a disease model, healthy behaviour is not necessarily desirable and the same CCG RA 
conditions may simply rescue the keratoconic behaviour of the diseased stromal cells. This 
initial analysis of culture conditions did show that CCG RA would be the best candidate 
model system for further refinement and development into a more complete model of the 
healthy stroma, perhaps culminating into a corneal model. The most obvious next step would 
be the 3 genes that could not be expressed to their original levels: KERA, MMP2 and CD34. 
The exact reasons why these gene expression levels fell are somewhat unclear. In the case of 
CD34, it has previously been observed that culture in serum medium led to a loss of CD34 
expression that could not be recovered (Perrella et al., 2007). It seems likely that the initial 
bulking phase in serum medium to produce large numbers of cells led to an irreversible loss 
of CD34 expression. Avoiding serum culture seems difficult, as large numbers of cells are 
needed for the construction of models, be it disease model or healthy tissue model.  
 
An important consideration in regards to the qPCR approach to model validation presented 
here is that CCG RA was only confirmed as a potential model of the healthy stroma, not the 
keratoconic stroma. It may very well be that if fresh keratoconic cells were compared to 
keratoconic cells cultured in this model, the two could be completely different. The model 
could be forcing healthy behaviour from the stromal cells cultured within. It is possible for 
example that the RA concentration in keratoconic corneas is somehow altered, leading to or 
supporting the disease. The concentration of RA used here may be rescuing the keratoconic 
behaviour. RA concentration in particular is mentioned as, to the authors knowledge, it has 
never been investigated in keratoconic corneas. The acquisition of fresh keratoconic cells to 
form a gene expression baseline would be the most obvious next step if qPCR were to 
continue being used as a model validation method. 
 
RNA-Seq is a powerful technique used to identify gene expression across the large range and 
build a transcriptomic identity of cells or tissues. In this instance, we used RNA-Seq to 
identify differences in gene expression between our model and two ethnically distinct groups 
of keratoconus patients. This was done in order to assess the validity of the model constructed 
as well as identify particular target genes that may need to be pursued further as design of this 
model continues. PCA initially showed that the model’s transcription profile did not resemble 
either of the patient groups. Also, as predicted, there was some difference between the two 
patient groups, however this remains to be further explored in future work. 
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While the keratoconic model showed overall little similarity with either patient group, 
narrowing gene expression profile down to the 14 genes previously assayed in our qPCR 
analysis showed that the European Caucasian group was most similar, or rather “least 
different”, with three genes expression appearing similar in both model and patients.  
 
Keratin presence has been documented in the stroma (Xuan et al., 2016) although the high 
level of multiple keratin types (keratin types 24, 6, 3, 14, 12 and 5) suggests that the 
epithelia’s gene expression was also part of the analysis. If that is the case, it could mean that 
the comparison between model and patient sample is not ideal, as the model does not yet 
integrate the epithelium in culture. Future work may aim to redo the validation after 
eliminating epithelial gene expression or add epithelial cells to the model. The challenge of 
obtaining keratoconic epithelial cells and culturing these for any significant period of time 
remains to be tackled. 
 
Some crystallins were found to be more expressed in the model system, particularly crystallin 
gamma N and crystalline (CRYGN) beta-gamma domain containing 2 (CRYBG2). 
Crystallins are an important family of proteins for corneal and lens function in humans and 
vertebrates in general. However, crystallin gamma N is an oddity in primates and humans, it 
simply isn’t expressed due a highly conserved stop codon mutation that sometimes leads to a 
longer, non-functional transcript. The exact reason why a large fold change occurred 
suggesting the model expressed a protein that likely doesn’t occur in human cornea is unclear 
and somewhat concerning, considering that building a model requires the cells to behave at 
least like human cells. The second crystallin of interest was CRYBG2, a member of the 
crystallin beta-gamma family with no single clear functional role. The more well documented 
member of this family, like gamma-S and beta-S crystallins, seem to be involved in actin 
binding within the lens (Quax-Jeuken et al., 1985, Fan et al., 2012). Similar to chaperone 
proteins, this specific family of crystallins seems to be shepherding larger oligomers to 
prevent aggregation (Wistow, 2012). A similarly functioning gene was also found to be 
lacking in the model and more present in the patients, HSPA1B. HSPA1B codes for a 
chaperone protein and a member of the Hsp70 family, a highly conserved ubiquitous group of 
molecular chaperones (Radons, 2016). HSPA1B, like most heat shock proteins, expression is 
well documented as being stress inducible and having increased expression during immune 
activity (Lindquist and Craig, 1988). The lack of chaperone protein gene expression in our 
model could indicate a lack of stress. The cells were harvested from diseased tissue and 
cultivated in optimal conditions, similar to what may be found in a healthy cornea, as 
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exemplified by the qPCR comparison of cultured healthy cells and fresh healthy cells. It may 
be that reintroducing as element of stress, potentially immune or inflammatory, could 
recapitulate more keratoconic gene expression in vitro. Experiments utilizing stress-
modulation have already shown some success in reproducing keratoconus-like transcription 
profiles (Soiberman et al., 2019). 
 
Throughout the gene expression analysis of keratoconic cells with qPCR, alpha smooth 
muscle actin or αSMA was repeatedly used as a marker of myofibroblastic differentiation. A 
particularly large rise was seen when first culturing keratoconic cells in gels and comparison 
to patients showed a decisive increase in αSMA expression in the model. ACTG2 is another 
smooth muscle actin that had apparently increased due to model culture, the cells definitely 
appear to be more contractile and likely more myofibroblastic. This differentiation could be 
considered a target for future development of the model. 
 
A final remarkable set of genes that saw great difference in comparing patient and model 
were those associated with retinoic acid, particularly RXRB and to a lesser extent RARRES2. 
RXRB is a nuclear retinoic acid receptor that dimerizes with other retinoic acid receptors, 
such as the previously mentioned RARA. RXRB is the most abundantly expressed of the six 
retinoic acid receptors in the cornea and is the only one that doesn’t show dynamic expression 
patterns (Mori et al., 2001). However, its absence seems to have no effect, as null mutant 
animals do not exhibit abnormal eyes (Kastner et al., 1996). The significance of increased 
RXRB expression in the model system is difficult to interpret, as while absence of RXRB has 
been investigated, excess has not. Taken in its entirety, the RNA-Seq validation provided 
some sobering insight into how much remains to be done in order to build an ideal model 
while also indicating new avenues of investigation for future experiments. The model may yet 
be developed into a better reflection of the patient eye through epithelium integration and 
controlled stress induction among other techniques. 
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 Chapter 8: Conclusions and Future Directions 
1. Conclusions 
In this thesis we have assembled a culture system comprising of compressed collagen gels and 
serum-free medium supplemented with retinoic acid to culture primary keratoconic stromal 
cells for the purpose of disease modelling. 
 
Initially we investigated the effects of extraction method and location on the behaviour of the 
extracted population. We found that central and limbal cells differ in their survival and gene 
expression in all culture conditions, even after bulking in serum. We also found that while 
keratoconic cells were extracted from the central button via explant migration, they show very 
little similarity to healthy cells extracted from the same location with the same method. 
Instead, keratoconic cells most resembled the limbal cells extracted via enzyme digestion. 
This led to an initial theory that keratoconic cells were to some extent “displaced” limbal cells 
that may not have differentiated into the more function-orientated central cell identity. Further 
comparison between the limbal and keratoconic cells did show that there were some still some 
differences between the two cell types and that keratoconic cell possessed their own identity, 
at least as presented by analysis of gene expression. The differences observed among the six 
distinct populations of stromal cells we isolated constitute an interesting consideration for any 
future work utilising primary stromal cells. The variety in behaviour, survival and gene 
expression, shows that the data derived from cell extracted by enzyme digestion may not be 
easily compared to data derived from cells that were explant migrated. Considering that the 
differences seen here were in tissue from the same donor (center and limbus from the same 
cornea, explant migration and enzyme digestion from the left and right corneas), using 
different donors and different extraction methods could no doubt yield greatly different cell 
identities. Establishing the effects of cell extraction method and location would aid future 
analysis of the work done on stromal cells and even build towards a standardisation effort in 
the techniques surrounding primary stromal cell extraction. 
 
Following the extraction of the stromal cells, we sought to maintain a large population alive in 
vitro, as a first step towards model construction. Retinoic acid (RA) proved entirely effective 
in that pursuit and even lead to proliferation of stromal cells in serum-free conditions. RA 
seemed to affect the expression of ALDH3A1 the most, with very significant increases in 
expression being seen in all cell types upon addition of RA.  
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One of the first model requirements decided in the planning phase was that the culture system 
would be 3D to emulate the stromal tissue. This was achieved using one of the most 
thoroughly documented biomaterials: collagen. By compressing the collagen gel, we obtained 
a thin, semi-transparent disc reminiscent of the corneal stroma. The cells within behaved very 
differently than when cultured on flat plastic. Increases were seen in the expression of genes 
coding for digestive enzymes and crosslinkers, suggesting that cells were now remodelling 
the surrounding matrix. Also, of interest is that the toxicity threshold of retinoic acid seemed 
to change with 3D culture. This seems relevant particularly in future experimental planning 
and understanding previous work that compared 2D and 3D systems. Indeed, if the sensitivity 
of stromal cells could change for retinoic acid, what other supplement could be having a 
different effect in 3D?  
 
Analysis of the gene expression profiles of healthy limbal cells revealed that compressed 
collagen gels and retinoic acid provided an environment that best simulated natural stromal 
cells behaviour in serum-free conditions. To then further refine the model, curvature was 
suggested as an additional environmental cue. Curving gels prove to have little beneficial 
effect in modelling the healthy cornea, as gene expression patterns seemed distant from the 
baseline control. It would seem that flat gels performed better that curved gels, although it is 
difficult to discern the exact mechanics underlying this difference in response. 
 
The inverse relationship observed in KERA and MMP, where KERA increase while MMP1 
drops, was also noteworthy. The absence of KERA results in deformation of the cornea but 
without impacting the expression of other crosslinkers and collagens. This is unlike LUM 
absence, which did reduce collagen expression. KERA absence must have deformed the 
cornea via another mechanism, potentially MMP1. MMP1 appears suspect due to our 
observation that with every KERA expression increase, MMP1 expression decreases. Further 
investigation into the relationship between these two genes and their expressed proteins could 
prove fruitful in elucidating the degradative regulation of the cornea. 
 
The work presented here is supported a small number of samples (3 samples of keratoconic 
tissue and 3 samples of 3 healthy tissue), this means that any variations across donors would 
greatly affect results. The healthy samples were also all female and with an average age of 75; 
while the keratoconic sample age and sex were unknown, based on demographic data they 
were likely males in around the age of 30. It is very possible that differences seen between the 
two groups (healthy and keratoconic) were entirely due to age, sex, or a combination of both. 
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While some effort was made to support differences seen with literature, future experiments 
should aim to collect healthy tissue from young donors of both sexes and, if possible, from 
multiple ethnicities. 
 
It is known and documented that the corneal stroma changes with age. Increases in haziness 
and density are usually observed clinically as patients age, even in healthy individuals 
(Stocker & Moore, 1975; Weale, 1963). Within the stromal matrix, the collagen fibrils also 
change with age showing dysregulation in spacing (Kanai & Kaufman, 1973). Interfibrillar 
spacing often decreased with age, accompanied by increased collagen glycation and greater 
presence of glycation end-products (Malik et al., 1992). Interestingly these glycation changes 
would contribute to a stiffer tissue and are posited to be the main reasons why keratoconus 
does not progress in older patients. This means that differences observed here between a 
likely young keratoconic donor group and an aged healthy control group may be due to aging, 
particularly with regards to interfibrillar spacing-related gene like collagen type V. 
 
The final test of the model with RNA-Seq by comparing the cultured keratoconic cells to real 
samples harvested from two patient groups revealed that the model differs greatly from the 
patient tissue. While it is possible that patient samples had epithelial tissue adding an extra 
dimension to the complex transcriptome, the evident difference in stromal cell specific genes 
confirm the model is far from perfect. Further engagement of a keratoconic cell identity could 
no doubt still be achieved in vitro thought the use of environmental conditions such as stress, 
epithelial cells, low-glucose or even a shaped mould.  
 
The construction of a stromal model and its subsequent troubleshooting has allowed us to 
identify specific gene expression patterns that were then used to assess a model of 
keratoconus. The data presented raised several questions regarding the mechanism involved in 
cell maintenance in vitro and the different cell populations in vivo. The study of stromal cell 
extraction method and location presented here would certainly be of great use to the entire 
field of corneal research during experimental planning. Extracting and culturing the right cell 
for an experiment is important and the basic characterisation shown here supports this 
importance regarding stromal cells. Concerning the construction of keratoconus models, the 




2. Future directions 
Early in the work on isolation of stromal cells from the cornea it was found that keratoconic 
cells consistently behaved like enzyme digested limbal cells. This was particularly obvious in 
the case of survival and the expression of a few genes. The nature of this similarity could not 
be fully explored here and remains a tantalizing comparison. If the disease is partly due to 
relocation or poor differentiation of limbal cells in the corneal centre, this could have 
significant implications in future treatment design. For now, it remains an interesting 
observation. 
 
As with all model designing experiment, the obvious next step is the addition of more signals 
or traits found in the original disease system into the model in order to best replicate the 
disease. In the case of a corneal model, adding the two missing cell populations, epithelial and 
endothelial cells, could prove difficult yet result in a more realistic model of the cornea as a 
whole. Another obvious feature to change is the glucose concentration of the medium. 
Previous work did show that lower glucose concentrations closer to what is observed in the 
stroma can enhance cell survival and expression of CD34, a particular marker we could not 
express at in vivo levels in our model (Foster et al., 2015). Greater and more varied 
characterization efforts of the model throughout these design phases would be of great help in 
discerning what each condition is causing in the cells. Proteomics in particular would be of 
interest, as the transcriptomic data presented in this work could prove useful in comparing 
translation and transcription. While a greater number of patient tissue samples would be 
obviously desirable, a greater diversity in ethnic sources and sex effects would be of value. 
This is because some previous research has found evidence of sex affecting gene expression 
in the keratoconic cornea (You et al., 2018). As for ethnicity, specific groups have been 
determined to be more at risk than others and may even develop conditions associated with 
keratoconus (Georgiou et al., 2004). Since the goal of this model is partly to build greater 
understanding of the disease, as many samples as possible should collected from diverse 
sources. The extraction techniques, assays, data and observations exposed here would no 
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